BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drosten C, Günther S, Preiser W, van der Werf S, Brodt H, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguière A, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra J, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk H, Osterhaus AD, Schmitz H, Doerr HW. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. N Engl J Med 2003;348:1967-76. [DOI: 10.1056/nejmoa030747] [Cited by in Crossref: 2752] [Cited by in F6Publishing: 2015] [Article Influence: 144.8] [Reference Citation Analysis]
Number Citing Articles
1 Anderson LJ. Human bocavirus: a new viral pathogen. Clin Infect Dis 2007;44:911-2. [PMID: 17342640 DOI: 10.1086/512438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ho MS, Chen WJ, Chen HY, Lin SF, Wang MC, Di J, Lu YT, Liu CL, Chang SC, Chao CL, King CC, Chiou JM, Su IJ, Yang JY. Neutralizing antibody response and SARS severity. Emerg Infect Dis 2005;11:1730-7. [PMID: 16318725 DOI: 10.3201/eid1111.040659] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 5.9] [Reference Citation Analysis]
3 Wang B, Potter SJ, Lin Y, Cunningham AL, Dwyer DE, Su Y, Ma X, Hou Y, Saksena NK. Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. J Clin Microbiol 2005;43:2339-44. [PMID: 15872263 DOI: 10.1128/JCM.43.5.2339-2344.2005] [Cited by in Crossref: 102] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
4 Vogt TM, Guerra MA, Flagg EW, Ksiazek TG, Lowther SA, Arguin PM. Risk of severe acute respiratory syndrome-associated coronavirus transmission aboard commercial aircraft. J Travel Med 2006;13:268-72. [PMID: 16987125 DOI: 10.1111/j.1708-8305.2006.00048.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
5 Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One. 2012;7:e35421. [PMID: 22536382 DOI: 10.1371/journal.pone.0035421] [Cited by in Crossref: 267] [Cited by in F6Publishing: 283] [Article Influence: 26.7] [Reference Citation Analysis]
6 J Alsaadi EA, Jones IM. Membrane binding proteins of coronaviruses. Future Virol 2019;14:275-86. [PMID: 32201500 DOI: 10.2217/fvl-2018-0144] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 30.0] [Reference Citation Analysis]
7 Fontanet A. Les enseignements du SRAS. La Presse Médicale 2007;36:299-302. [DOI: 10.1016/j.lpm.2006.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Lin HX, Feng Y, Tu X, Zhao X, Hsieh CH, Griffin L, Junop M, Zhang C. Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. Virus Res 2011;160:283-93. [PMID: 21798295 DOI: 10.1016/j.virusres.2011.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
9 Nyaguthii DM, Otieno GP, Kombe IK, Koech D, Mutunga M, Medley GF, Nokes DJ, Munywoki PK. Infection patterns of endemic human coronaviruses in rural households in coastal Kenya. Wellcome Open Res 2021;6:27. [PMID: 34957334 DOI: 10.12688/wellcomeopenres.16508.1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Egloff MP, Ferron F, Campanacci V, Longhi S, Rancurel C, Dutartre H, Snijder EJ, Gorbalenya AE, Cambillau C, Canard B. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci USA. 2004;101:3792-3796. [PMID: 15007178 DOI: 10.1073/pnas.0307877101] [Cited by in Crossref: 177] [Cited by in F6Publishing: 149] [Article Influence: 9.8] [Reference Citation Analysis]
11 Lu HY, Huo N, Wang GF, Li HC, Nie LG, Que CL, Li J, Li YH, Gao XM, Zhao ZD, Zhuang H, Xu XY. Influence of factors on production of IgG antibody in SARS patients. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 723-725 [DOI: 10.11569/wcjd.v12.i3.723] [Reference Citation Analysis]
12 Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, Wong MM, Hui WT, Poon LL, Tse DM, Chan KS, Woo PC, Lau SK, Peiris JS, Yuen KY. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004;10:1550-1557. [PMID: 15498155 DOI: 10.3201/eid1009.040058] [Cited by in Crossref: 174] [Cited by in F6Publishing: 153] [Article Influence: 9.7] [Reference Citation Analysis]
13 Carbajo-Lozoya J, Müller MA, Kallies S, Thiel V, Drosten C, von Brunn A. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res 2012;165:112-7. [PMID: 22349148 DOI: 10.1016/j.virusres.2012.02.002] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 13.4] [Reference Citation Analysis]
14 DeDiego ML, Nieto-Torres JL, Jiménez-Guardeño JM, Regla-Nava JA, Alvarez E, Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog 2011;7:e1002315. [PMID: 22028656 DOI: 10.1371/journal.ppat.1002315] [Cited by in Crossref: 122] [Cited by in F6Publishing: 113] [Article Influence: 11.1] [Reference Citation Analysis]
15 Dittmer U, Sutter K, Kassiotis G, Zelinskyy G, Bánki Z, Stoiber H, Santiago ML, Hasenkrug KJ. Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity. FEMS Microbiol Rev 2019;43:435-56. [PMID: 31087035 DOI: 10.1093/femsre/fuz012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Millet JK, Kien F, Cheung CY, Siu YL, Chan WL, Li H, Leung HL, Jaume M, Bruzzone R, Peiris JS, Altmeyer RM, Nal B. Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage. PLoS One 2012;7:e49566. [PMID: 23185364 DOI: 10.1371/journal.pone.0049566] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
17 Liu W, Reyes HM, Yang JF, Li Y, Stewart KM, Basil MC, Lin SM, Katzen J, Morrisey EE, Weiss SR, You J. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection. J Virol 2021;95:e00490-21. [PMID: 33789998 DOI: 10.1128/JVI.00490-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Fan K, Wei P, Feng Q, Chen S, Huang C, Ma L, Lai B, Pei J, Liu Y, Chen J, Lai L. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem 2004;279:1637-42. [PMID: 14561748 DOI: 10.1074/jbc.M310875200] [Cited by in Crossref: 199] [Cited by in F6Publishing: 151] [Article Influence: 10.5] [Reference Citation Analysis]
19 Tang L, Yin Z, Hu Y, Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front Immunol 2020;11:570993. [PMID: 33329533 DOI: 10.3389/fimmu.2020.570993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
20 He B, Zhang Y, Xu L, Yang W, Yang F, Feng Y, Xia L, Zhou J, Zhen W, Feng Y, Guo H, Zhang H, Tu C. Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. J Virol 2014;88:7070-82. [PMID: 24719429 DOI: 10.1128/JVI.00631-14] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 11.0] [Reference Citation Analysis]
21 Cuong HQ, Hai ND, Linh HT, Anh NH, Hieu NT, Thang CM, Thao NTT, Lan PT. Comparison of Primer-Probe Sets among Different Master Mixes for Laboratory Screening of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Biomed Res Int 2020;2020:7610678. [PMID: 33029522 DOI: 10.1155/2020/7610678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Sun Y, Zhang H, Shi J, Zhang Z, Gong R. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus. Viruses 2017;9:E255. [PMID: 28906430 DOI: 10.3390/v9090255] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
23 Keuleyan E. Liberty to decide on dual use biomedical research: an acknowledged necessity. Sci Eng Ethics 2010;16:43-58. [PMID: 18427955 DOI: 10.1007/s11948-008-9064-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Bakharev SD, Baulo EV, Bykova SV, Dbar SR, Parfenov AI. COVID-19 and the small intestine. Terapevticheskii arkhiv 2021;93:343-7. [DOI: 10.26442/00403660.2021.03.200662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Jabbour P, Sweid A, Tjoumakaris S, Piotin M, Brinjikji W, Bekelis K, Raz E, Sourour N, Nimjee SM, Lopes DK, Hassan AE, Pandey AS, Gonzalez LF, Hanel RA, Siddiqui AH, Hasan D, Lavine SD, Bendok BR. In Reply: May Cooler Heads Prevail During a Pandemic: Stroke in COVID-19 Patients or COVID-19 in Stroke Patients? Neurosurgery 2020:nyaa384. [PMID: 32856706 DOI: 10.1093/neuros/nyaa384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Neufurth M, Wang X, Tolba E, Lieberwirth I, Wang S, Schröder HC, Müller WEG. The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations. Biochem Pharmacol 2020;182:114215. [PMID: 32905794 DOI: 10.1016/j.bcp.2020.114215] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
27 Panwar VS, Sheik Uduman PS, Gómez-Aguilar JF. Mathematical modeling of coronavirus disease COVID-19 dynamics using CF and ABC non-singular fractional derivatives. Chaos Solitons Fractals 2021;145:110757. [PMID: 33558794 DOI: 10.1016/j.chaos.2021.110757] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
28 Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D, Junglen S. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13:745-751. [PMID: 23782859 DOI: 10.1016/s1473-3099(13)70154-3] [Cited by in Crossref: 266] [Cited by in F6Publishing: 228] [Article Influence: 29.6] [Reference Citation Analysis]
29 Noor R, Shareen S, Billah M. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00787-z] [Reference Citation Analysis]
30 Kiselev D, Matsvay A, Abramov I, Dedkov V, Shipulin G, Khafizov K. Current Trends in Diagnostics of Viral Infections of Unknown Etiology. Viruses 2020;12:E211. [PMID: 32074965 DOI: 10.3390/v12020211] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
31 Leijon M, Mousavi-Jazi M, Kubista M. LightUp probes in clinical diagnostics. Mol Aspects Med 2006;27:160-75. [PMID: 16466783 DOI: 10.1016/j.mam.2005.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
32 Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W, Li J, Zhou Z, Ding Y, Zhao Q, Zhang XC, Liao M, Bartlam M, Rao Z. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J Virol 2008;82:2515-27. [PMID: 18094151 DOI: 10.1128/JVI.02114-07] [Cited by in Crossref: 244] [Cited by in F6Publishing: 148] [Article Influence: 16.3] [Reference Citation Analysis]
33 Almaeen AH, Alduraywish AA, Ghazy AA, El-Metwally TH, Alayyaf M, Alrayes FH, Alinad AKM, Albulayhid SBH, Aldakhil AR, Taha AE. The Pre-Vaccination Donated Blood Is Free from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) but Is Rich with Anti-SARS-CoV-2 Antibodies: A Cross-Section Saudi Study. Int J Environ Res Public Health 2022;19:7119. [PMID: 35742368 DOI: 10.3390/ijerph19127119] [Reference Citation Analysis]
34 V'kovski P, Steiner S, Thiel V. Proximity Labeling for the Identification of Coronavirus-Host Protein Interactions. Methods Mol Biol 2020;2203:187-204. [PMID: 32833213 DOI: 10.1007/978-1-0716-0900-2_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lu S, Lin S, Zhang H, Liang L, Shen S. Methods of Respiratory Virus Detection: Advances towards Point-of-Care for Early Intervention. Micromachines (Basel) 2021;12:697. [PMID: 34203612 DOI: 10.3390/mi12060697] [Reference Citation Analysis]
36 Hsu HH, Tzao C, Wu CP, Chang WC, Tsai CL, Tung HJ, Chen CY. Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome. Chest 2004;126:149-58. [PMID: 15249456 DOI: 10.1378/chest.126.1.149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
37 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Chen Y, Tao J, Sun Y, Wu A, Su C, Gao G, Cai H, Qiu S, Wu Y, Ahola T, Guo D. Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase. J Virol 2013;87:6296-305. [PMID: 23536667 DOI: 10.1128/JVI.00061-13] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
39 Ponnusamy R, Moll R, Weimar T, Mesters JR, Hilgenfeld R. Variable oligomerization modes in coronavirus non-structural protein 9. J Mol Biol. 2008;383:1081-1096. [PMID: 18694760 DOI: 10.1016/j.jmb.2008.07.071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
40 Mendenhall IH, Borthwick S, Neves ES, Low D, Linster M, Liang B, Skiles M, Jayakumar J, Han H, Gunalan V, Lee BPY, Okahara K, Wang LF, Maurer-Stroh S, Su YCF, Smith GJD. Identification of a Lineage D Betacoronavirus in Cave Nectar Bats (Eonycteris spelaea) in Singapore and an Overview of Lineage D Reservoir Ecology in SE Asian Bats. Transbound Emerg Dis 2017;64:1790-800. [PMID: 27637887 DOI: 10.1111/tbed.12568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wu CH, Yeh SH, Tsay YG, Shieh YH, Kao CL, Chen YS, Wang SH, Kuo TJ, Chen DS, Chen PJ. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J Biol Chem 2009;284:5229-39. [PMID: 19106108 DOI: 10.1074/jbc.M805747200] [Cited by in Crossref: 105] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
42 Simon A, Völz S, Höfling K, Kehl A, Tillman R, Müller A, Kupfer B, Eis-Hübinger AM, Lentze MJ, Bode U, Schildgen O. Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229E infection. Pediatr Pulmonol 2007;42:393-6. [PMID: 17352399 DOI: 10.1002/ppul.20595] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
43 Pereira GJDS, Leão AHFF, Erustes AG, Morais IBM, Vrechi TAM, Zamarioli LDS, Pereira CAS, Marchioro LO, Sperandio LP, Lins ÍVF, Piacentini M, Fimia GM, Reckziegel P, Smaili SS, Bincoletto C. Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. Int J Mol Sci 2021;22:4067. [PMID: 33920748 DOI: 10.3390/ijms22084067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
44 World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003;361:1730-3. [PMID: 12767752 DOI: 10.1016/s0140-6736(03)13376-4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
45 Verbeek PR, McClelland IW, Silverman AC, Burgess RJ. Loss of paramedic availability in an urban emergency medical services system during a severe acute respiratory syndrome outbreak. Acad Emerg Med 2004;11:973-8. [PMID: 15347550 DOI: 10.1197/j.aem.2004.03.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
46 Brug J, Aro AR, Richardus JH. Risk perceptions and behaviour: towards pandemic control of emerging infectious diseases : international research on risk perception in the control of emerging infectious diseases. Int J Behav Med 2009;16:3-6. [PMID: 19127440 DOI: 10.1007/s12529-008-9000-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
47 Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z, Tan W. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep 2015;5:17554. [PMID: 26631542 DOI: 10.1038/srep17554] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
48 Andrés C, Piñana M, Borras-Bermejo B, González-Sánchez A, García-Cehic D, Esperalba J, Rando A, Zules-Oña RG, Campos C, Codina MG, Blanco-Grau A, Colomer-Castell S, Martín MC, Castillo C, García-Comuñas K, Vásquez-Mercado R, Martins-Martins R, Campins-Martí M, Pumarola T, Quer J, Antón A. A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain). Emerg Microbes Infect 2021;:1-30. [PMID: 34842496 DOI: 10.1080/22221751.2021.2011617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
49 Lehtoranta L, Söderlund-Venermo M, Nokso-Koivisto J, Toivola H, Blomgren K, Hatakka K, Poussa T, Korpela R, Pitkäranta A. Human bocavirus in the nasopharynx of otitis-prone children. Int J Pediatr Otorhinolaryngol 2012;76:206-11. [PMID: 22119148 DOI: 10.1016/j.ijporl.2011.10.025] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
50 Wilder-Smith A, Leong HN, Villacian JS. In-flight transmission of Severe Acute Respiratory Syndrome (SARS): a case report. J Travel Med 2003;10:299-300. [PMID: 14531986 DOI: 10.2310/7060.2003.2737] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
51 Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. [PMID: 16968120 DOI: 10.1371/journal.pmed.0030343] [Cited by in Crossref: 694] [Cited by in F6Publishing: 615] [Article Influence: 46.3] [Reference Citation Analysis]
52 Ferrari D, Carobene A, Campagner A, Cabitza F, Sabetta E, Ceriotti D, Di Resta C, Locatelli M. Evidence of significant difference in key COVID-19 biomarkers during the Italian lockdown strategy. A retrospective study on patients admitted to a hospital emergency department in Northern Italy. Acta Biomed 2020;91:e2020156. [PMID: 33525206 DOI: 10.23750/abm.v91i4.10371] [Reference Citation Analysis]
53 Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway. J Virol 2011;85:10582-97. [PMID: 21775467 DOI: 10.1128/JVI.00671-11] [Cited by in Crossref: 215] [Cited by in F6Publishing: 148] [Article Influence: 19.5] [Reference Citation Analysis]
54 Chu CM, Poon LL, Cheng VC, Chan KS, Hung IF, Wong MM, Chan KH, Leung WS, Tang BS, Chan VL, Ng WL, Sim TC, Ng PW, Law KI, Tse DM, Peiris JS, Yuen KY. Initial viral load and the outcomes of SARS. CMAJ. 2004;171:1349-1352. [PMID: 15557587 DOI: 10.1503/cmaj.1040398] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 6.6] [Reference Citation Analysis]
55 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
56 Rehman S, Majeed T, Azam Ansari M, Ali U, Sabit H, Al-Suhaimi EA. Current Scenario of COVID-19 in Pediatric Age Group and Physiology of Immune and Thymus response. Saudi J Biol Sci 2020. [PMID: 32425651 DOI: 10.1016/j.sjbs.2020.05.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
57 Du Q, Wang S, Wei D, Sirois S, Chou KC. Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase. Anal Biochem 2005;337:262-70. [PMID: 15691506 DOI: 10.1016/j.ab.2004.10.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
58 Bahadur S, Long W, Shuaib M. Human coronaviruses with emphasis on the COVID-19 outbreak. Virusdisease 2020;:1-5. [PMID: 32399479 DOI: 10.1007/s13337-020-00594-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Westhaus S, Weber FA, Schiwy S, Linnemann V, Brinkmann M, Widera M, Greve C, Janke A, Hollert H, Wintgens T, Ciesek S. Detection of SARS-CoV-2 in raw and treated wastewater in Germany - Suitability for COVID-19 surveillance and potential transmission risks. Sci Total Environ 2021;751:141750. [PMID: 32861187 DOI: 10.1016/j.scitotenv.2020.141750] [Cited by in Crossref: 95] [Cited by in F6Publishing: 68] [Article Influence: 47.5] [Reference Citation Analysis]
60 Jin Y, Song JR, Xie ZP, Gao HC, Yuan XH, Xu ZQ, Yan KL, Zhao Y, Xiao NG, Hou YD, Duan ZJ. Prevalence and clinical characteristics of human CoV-HKU1 in children with acute respiratory tract infections in China. J Clin Virol 2010;49:126-30. [PMID: 20702134 DOI: 10.1016/j.jcv.2010.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
61 Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, Kehrl JH. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol 2014;193:3080-9. [PMID: 25135833 DOI: 10.4049/jimmunol.1303196] [Cited by in Crossref: 236] [Cited by in F6Publishing: 224] [Article Influence: 29.5] [Reference Citation Analysis]
62 Li X. Concerns on the multiple nomenclature systems for SARS-CoV-2. J Med Virol 2021. [PMID: 34672373 DOI: 10.1002/jmv.27406] [Reference Citation Analysis]
63 Gundamaraju R, Vemuri RC, Hwi KK. Are animals a bane for the spread of the deadly malady, the corona virus (MERS)? Asian Pac J Trop Biomed 2014;4:S46-7. [PMID: 25183129 DOI: 10.12980/APJTB.4.2014C1220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Chang CK, Hsu YL, Chang YH, Chao FA, Wu MC, Huang YS, Hu CK, Huang TH. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging. J Virol 2009;83:2255-64. [PMID: 19052082 DOI: 10.1128/JVI.02001-08] [Cited by in Crossref: 116] [Cited by in F6Publishing: 80] [Article Influence: 8.3] [Reference Citation Analysis]
65 Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl:S9-14. [PMID: 15018127 DOI: 10.1046/j.1440-1843.2003.00518.x] [Cited by in Crossref: 320] [Cited by in F6Publishing: 261] [Article Influence: 17.8] [Reference Citation Analysis]
66 Hu T, Qiu W, He B, Zhang Y, Yu J, Liang X, Zhang W, Chen G, Zhang Y, Wang Y, Zheng Y, Feng Z, Hu Y, Zhou W, Tu C, Fan Q, Zhang F. Characterization of a novel orthoreovirus isolated from fruit bat, China. BMC Microbiol 2014;14:293. [PMID: 25433675 DOI: 10.1186/s12866-014-0293-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
67 Braden CR, Dowell SF, Jernigan DB, Hughes JM. Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome. Emerg Infect Dis 2013;19:864-9. [PMID: 23731871 DOI: 10.3201/eid1906.130192] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
68 Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y. Precision therapeutic targets for COVID-19. Virol J 2021;18:66. [PMID: 33781287 DOI: 10.1186/s12985-021-01526-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Kumar D, Humar A. Respiratory viral infections in transplant and oncology patients. Infect Dis Clin North Am 2010;24:395-412. [PMID: 20466276 DOI: 10.1016/j.idc.2010.01.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
70 Follis KE, York J, Nunberg JH. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 2006;350:358-69. [PMID: 16519916 DOI: 10.1016/j.virol.2006.02.003] [Cited by in Crossref: 142] [Cited by in F6Publishing: 121] [Article Influence: 8.9] [Reference Citation Analysis]
71 Kumakamba C, Niama FR, Muyembe F, Mombouli JV, Kingebeni PM, Nina RA, Lukusa IN, Bounga G, N'Kawa F, Nkoua CG, Atibu Losoma J, Mulembakani P, Makuwa M, Tamufe U, Gillis A, LeBreton M, Olson SH, Cameron K, Reed P, Ondzie A, Tremeau-Bravard A, Smith BR, Pante J, Schneider BS, McIver DJ, Ayukekbong JA, Hoff NA, Rimoin AW, Laudisoit A, Monagin C, Goldstein T, Joly DO, Saylors K, Wolfe ND, Rubin EM, Bagamboula MPassi R, Muyembe Tamfum JJ, Lange CE. Coronavirus surveillance in wildlife from two Congo basin countries detects RNA of multiple species circulating in bats and rodents. PLoS One 2021;16:e0236971. [PMID: 34106949 DOI: 10.1371/journal.pone.0236971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Mochalov K, Samokhvalov P, Nifontova G, Tsoi T, Sukhanova A, Nabiev I. Surface-enhanced Raman scattering of CoV-SARS-2 viral proteins in a strong coupling regime. J Phys : Conf Ser 2021;2058:012020. [DOI: 10.1088/1742-6596/2058/1/012020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Konno H, Onuma T, Nitanai I, Wakabayashi M, Yano S, Teruya K, Akaji K. Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor. Bioorg Med Chem Lett 2017;27:2746-51. [PMID: 28454669 DOI: 10.1016/j.bmcl.2017.04.056] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
74 Kishk SM, Kishk RM, Yassen ASA, Nafie MS, Nemr NA, ElMasry G, Al-Rejaie S, Simons C. Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies. Molecules 2020;25:E5007. [PMID: 33137894 DOI: 10.3390/molecules25215007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Wickramaarachchi WPTM, Perera SSN, Jayasinghe S. COVID-19 Epidemic in Sri Lanka: A Mathematical and Computational Modelling Approach to Control. Comput Math Methods Med 2020;2020:4045064. [PMID: 33101453 DOI: 10.1155/2020/4045064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ng ML, Lee JW, Leong ML, Ling AE, Tan HC, Ooi EE. Topographic changes in SARS coronavirus-infected cells at late stages of infection. Emerg Infect Dis 2004;10:1907-14. [PMID: 15550199 DOI: 10.3201/eid1011.040195] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
77 Bozkurt F, Yousef A, Baleanu D, Alzabut J. A mathematical model of the evolution and spread of pathogenic coronaviruses from natural host to human host. Chaos Solitons Fractals 2020;138:109931. [PMID: 32536758 DOI: 10.1016/j.chaos.2020.109931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
78 Kaye M. SARS-associated coronavirus replication in cell lines. Emerg Infect Dis 2006;12:128-33. [PMID: 16494729 DOI: 10.3201/eid1201.050496] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
79 Nieto-Torres JL, Dediego ML, Alvarez E, Jiménez-Guardeño JM, Regla-Nava JA, Llorente M, Kremer L, Shuo S, Enjuanes L. Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein. Virology 2011;415:69-82. [PMID: 21524776 DOI: 10.1016/j.virol.2011.03.029] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 10.4] [Reference Citation Analysis]
80 Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, Druce J, de Vries JJC, Kikkert M, Bárcena M, Sidorov I, Snijder EJ. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol 2020;101:925-40. [PMID: 32568027 DOI: 10.1099/jgv.0.001453] [Cited by in Crossref: 170] [Cited by in F6Publishing: 151] [Article Influence: 85.0] [Reference Citation Analysis]
81 Zhu J, Xiao G, Xu Y, Yuan F, Zheng C, Liu Y, Yan H, Cole DK, Bell JI, Rao Z, Tien P, Gao GF. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochem Biophys Res Commun 2004;319:283-8. [PMID: 15158473 DOI: 10.1016/j.bbrc.2004.04.141] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
82 Kapadia SU, Rose JK, Lamirande E, Vogel L, Subbarao K, Roberts A. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 2005;340:174-82. [PMID: 16043204 DOI: 10.1016/j.virol.2005.06.016] [Cited by in Crossref: 121] [Cited by in F6Publishing: 117] [Article Influence: 7.1] [Reference Citation Analysis]
83 Tao Z, Zhou S, Yao R, Wen K, Da W, Meng Y, Yang K, Liu H, Tao L. COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis. Ann Transl Med 2020;8:528. [PMID: 32411751 DOI: 10.21037/atm.2020.04.26] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
84 Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005;45:580-90. [PMID: 15819680 DOI: 10.1111/j.0041-1132.2005.04316.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 7.2] [Reference Citation Analysis]
85 Celigoy J, McReynolds S, Caffrey M. The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation. Biochem Biophys Res Commun 2011;412:483-6. [PMID: 21835164 DOI: 10.1016/j.bbrc.2011.07.126] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
86 Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004;10:871-5. [PMID: 15247913 DOI: 10.1038/nm1080] [Cited by in Crossref: 494] [Cited by in F6Publishing: 479] [Article Influence: 27.4] [Reference Citation Analysis]
87 Conly JM, Johnston BL. SARS : A Tale of Two Epidemics. Can J Infect Dis 2003;14:147-9. [PMID: 18159447 DOI: 10.1155/2003/912170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
88 Geller C, Varbanov M, Duval RE. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 2012;4:3044-68. [PMID: 23202515 DOI: 10.3390/v4113044] [Cited by in Crossref: 204] [Cited by in F6Publishing: 165] [Article Influence: 20.4] [Reference Citation Analysis]
89 Poon LL, Chan KH, Peiris JS. Crouching tiger, hidden dragon: the laboratory diagnosis of severe acute respiratory syndrome. Clin Infect Dis 2004;38:297-9. [PMID: 14699466 DOI: 10.1086/380848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
90 Wong GW, Leung TF. Bird flu: lessons from SARS. Paediatr Respir Rev 2007;8:171-6. [PMID: 17574162 DOI: 10.1016/j.prrv.2007.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
91 Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, Wang W, Lian G, Yin X, Du L, Ren L, Wang J, He X, Li T, Deng H, Ding M. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004;190:1119-26. [PMID: 15319862 DOI: 10.1086/423286] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 5.3] [Reference Citation Analysis]
92 Ghosh AK, Xi K, Johnson ME, Baker SC, Mesecar AD. Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. Annu Rep Med Chem 2007;41:183-96. [PMID: 19649165 DOI: 10.1016/S0065-7743(06)41011-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
93 Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res 2014;194:145-58. [PMID: 25281913 DOI: 10.1016/j.virusres.2014.09.011] [Cited by in Crossref: 131] [Cited by in F6Publishing: 120] [Article Influence: 16.4] [Reference Citation Analysis]
94 Feng C, Liu Y, Lyu G, Shang S, Xia H, Zhang J, Irwin DM, Wang Z, Zhang S, Harrison P. Adaptive Evolution of the Fox Coronavirus Based on Genome-Wide Sequence Analysis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/9627961] [Reference Citation Analysis]
95 Singh J, Pandit P, McArthur AG, Banerjee A, Mossman K. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol J 2021;18:166. [PMID: 34389034 DOI: 10.1186/s12985-021-01633-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
96 Ar Gouilh M, Puechmaille SJ, Diancourt L, Vandenbogaert M, Serra-Cobo J, Lopez Roïg M, Brown P, Moutou F, Caro V, Vabret A, Manuguerra JC; EPICOREM consortium. SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world. Virology 2018;517:88-97. [PMID: 29482919 DOI: 10.1016/j.virol.2018.01.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
97 Ryu YB, Jeong HJ, Kim JH, Kim YM, Park JY, Kim D, Nguyen TT, Park SJ, Chang JS, Park KH, Rho MC, Lee WS. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem 2010;18:7940-7. [PMID: 20934345 DOI: 10.1016/j.bmc.2010.09.035] [Cited by in Crossref: 210] [Cited by in F6Publishing: 184] [Article Influence: 17.5] [Reference Citation Analysis]
98 Patiño-Galindo JÁ, Filip I, Chowdhury R, Maranas CD, Sorger PK, AlQuraishi M, Rabadan R. Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2. Genome Med 2021;13:124. [PMID: 34362430 DOI: 10.1186/s13073-021-00943-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Robertson CA, Lowther SA, Birch T, Tan C, Sorhage F, Stockman L, McDonald C, Lingappa JR, Bresnitz E. SARS and pregnancy: a case report. Emerg Infect Dis. 2004;10:345-348. [PMID: 15030710 DOI: 10.3201/eid1002.030736] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 5.3] [Reference Citation Analysis]
100 Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H. SARS-CoV-2 productively infects human gut enterocytes. Science 2020;369:50-4. [PMID: 32358202 DOI: 10.1126/science.abc1669] [Cited by in Crossref: 635] [Cited by in F6Publishing: 617] [Article Influence: 317.5] [Reference Citation Analysis]
101 Gorgulla C, Padmanabha Das KM, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Gechev M, Rose A, Lewis N, Hutcheson C, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber C, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience 2021;24:102021. [PMID: 33426509 DOI: 10.1016/j.isci.2020.102021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
102 Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 2003;100:13190-5. [PMID: 14585926 DOI: 10.1073/pnas.1835675100] [Cited by in Crossref: 566] [Cited by in F6Publishing: 531] [Article Influence: 29.8] [Reference Citation Analysis]
103 Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005;61:107-111. [PMID: 15923059 DOI: 10.1016/j.jhin.2004.12.023] [Cited by in Crossref: 142] [Cited by in F6Publishing: 123] [Article Influence: 8.4] [Reference Citation Analysis]
104 Theamboonlers A, Samransamruajkit R, Thongme C, Amonsin A, Chongsrisawat V, Poovorawan Y. Human coronavirus infection among children with acute lower respiratory tract infection in Thailand. Intervirology 2007;50:71-7. [PMID: 17139182 DOI: 10.1159/000097392] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
105 Wang X, Wang S, Sun L, Qin G. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis. Diabetes Res Clin Pract. 2020;164:108200. [PMID: 32407746 DOI: 10.1016/j.diabres.2020.108200] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
106 Scheuplein VA, Seifried J, Malczyk AH, Miller L, Höcker L, Vergara-Alert J, Dolnik O, Zielecki F, Becker B, Spreitzer I, König R, Becker S, Waibler Z, Mühlebach MD. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol 2015;89:3859-69. [PMID: 25609809 DOI: 10.1128/JVI.03607-14] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
107 Tong S, Lingappa JR, Chen Q, Shu B, LaMonte AC, Cook BT, Birge C, Chern SW, Liu X, Galloway R, Mai le Q, Ng WF, Yang JY, Butany J, Comer JA, Monroe SS, Beard SR, Ksiazek TG, Erdman D, Rota PA, Pallansch MA, Anderson LJ. Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. J Infect Dis 2004;190:1127-31. [PMID: 15319863 DOI: 10.1086/422849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
108 Gutiérrez-Álvarez J, Honrubia JM, Sanz-Bravo A, González-Miranda E, Fernández-Delgado R, Rejas MT, Zúñiga S, Sola I, Enjuanes L. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proc Natl Acad Sci U S A 2021;118:e2111075118. [PMID: 34686605 DOI: 10.1073/pnas.2111075118] [Reference Citation Analysis]
109 Khajanchi S, Sarkar K, Mondal J, Nisar KS, Abdelwahab SF. Mathematical modeling of the COVID-19 pandemic with intervention strategies. Results Phys 2021;25:104285. [PMID: 33977079 DOI: 10.1016/j.rinp.2021.104285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005;18:1-10. [PMID: 15272286 DOI: 10.1038/modpathol.3800247] [Cited by in Crossref: 209] [Cited by in F6Publishing: 186] [Article Influence: 12.3] [Reference Citation Analysis]
111 Chng WJ, Lai HC, Earnest A, Kuperan P. Haematological parameters in severe acute respiratory syndrome. Clin Lab Haematol 2005;27:15-20. [PMID: 15686503 DOI: 10.1111/j.1365-2257.2004.00652.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
112 Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res 2018;100:163-88. [PMID: 29551135 DOI: 10.1016/bs.aivir.2018.01.001] [Cited by in Crossref: 524] [Cited by in F6Publishing: 417] [Article Influence: 131.0] [Reference Citation Analysis]
113 Jie X, Hongmei Y, Ping F, Kuikui Z, Bohan Y, Rui M. Beneficial effect of Arbidol in the management of COVID-19 infection. Aging (Albany NY) 2021;13:9253-64. [PMID: 33811756 DOI: 10.18632/aging.202867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
114 Zhang J, Meng B, Liao D, Zhou L, Zhang X, Chen L, Guo Z, Peng C, Zhu B, Lee PP, Xu X, Zhou T, Deng Z, Hu Y, Li K. De novo synthesis of PCR templates for the development of SARS diagnostic assay. Mol Biotechnol 2003;25:107-12. [PMID: 14526121 DOI: 10.1385/MB:25:2:107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
115 Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, Yang KD, Lin MC, Wang YH, Liu JW, Eng HL, Chiang PC, Wu TS, Tsao KC, Huang CG, Tien YJ, Wang TH, Wang HS, Lee YS. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132. [PMID: 16174304 DOI: 10.1186/1471-2164-6-132] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
116 Roper RL, Rehm KE. SARS vaccines: where are we? Expert Rev Vaccines 2009;8:887-98. [PMID: 19538115 DOI: 10.1586/erv.09.43] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 8.5] [Reference Citation Analysis]
117 Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. Biochem Biophys Res Commun 2004;319:746-52. [PMID: 15184046 DOI: 10.1016/j.bbrc.2004.05.046] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 3.9] [Reference Citation Analysis]
118 Janice Oh HL, Ken-En Gan S, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect 2012;1:e23. [PMID: 26038429 DOI: 10.1038/emi.2012.26] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
119 Lu L, Manopo I, Leung BP, Chng HH, Ling AE, Chee LL, Ooi EE, Chan SW, Kwang J. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 2004;42:1570-6. [PMID: 15071006 DOI: 10.1128/JCM.42.4.1570-1576.2004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
120 Xu J, Yin Z, Liu Y, Wang S, Duan L, An Y, Fan J, Liao T, Jin Y, Chen J. Clinical characteristics and outcomes of severe or critical COVID-19 patients presenting no respiratory symptoms or fever at onset. Engineering (Beijing) 2020. [PMID: 33163252 DOI: 10.1016/j.eng.2020.09.009] [Reference Citation Analysis]
121 Kumari P, Rawat K, Saha L. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update. Curr Pharmacol Rep 2020;:1-13. [PMID: 32837854 DOI: 10.1007/s40495-020-00226-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
122 Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis. 2004;4:337-348. [PMID: 15172342 DOI: 10.1016/s1473-3099(04)01044-8] [Cited by in Crossref: 418] [Cited by in F6Publishing: 164] [Article Influence: 23.2] [Reference Citation Analysis]
123 Sparks JS, Donaldson EF, Lu X, Baric RS, Denison MR. A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing. J Virol 2008;82:5999-6008. [PMID: 18385240 DOI: 10.1128/JVI.00203-08] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
124 Zhang Z, Ma P, Ahmed R, Wang J, Akin D, Soto F, Liu BF, Li P, Demirci U. Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection. Adv Mater 2022;34:e2103646. [PMID: 34623709 DOI: 10.1002/adma.202103646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
125 Amoroso MG, Russo D, Lanave G, Cistrone L, Pratelli A, Martella V, Galiero G, Decaro N, Fusco G. Detection and phylogenetic characterization of astroviruses in insectivorous bats from Central-Southern Italy. Zoonoses Public Health 2018;65:702-10. [PMID: 29896884 DOI: 10.1111/zph.12484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
126 Jansson AM. Structure of alphacoronavirus transmissible gastroenteritis virus nsp1 has implications for coronavirus nsp1 function and evolution. J Virol 2013;87:2949-55. [PMID: 23269811 DOI: 10.1128/JVI.03163-12] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
127 Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat Immunol 2018;19:20-8. [PMID: 29199281 DOI: 10.1038/s41590-017-0007-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
128 Calvo E, DeDiego ML, García P, López JA, Pérez-Breña P, Falcón A. Severe acute respiratory syndrome coronavirus accessory proteins 6 and 9b interact in vivo. Virus Res 2012;169:282-8. [PMID: 22820404 DOI: 10.1016/j.virusres.2012.07.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
129 Drosten C, Chiu LL, Panning M, Leong HN, Preiser W, Tam JS, Günther S, Kramme S, Emmerich P, Ng WL, Schmitz H, Koay ES. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2004;42:2043-7. [PMID: 15131168 DOI: 10.1128/JCM.42.5.2043-2047.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
130 Cabero-Pérez MJ, Gómez-Acebo I, Dierssen-Sotos T, Llorca J. [Infection by SARS-CoV-2 in pregnancy and possibility of transmission to neonates: A systematic revision]. Semergen 2020;46 Suppl 1:40-7. [PMID: 32646729 DOI: 10.1016/j.semerg.2020.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
131 Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005;191:492-8. [PMID: 15655770 DOI: 10.1086/428138] [Cited by in Crossref: 143] [Cited by in F6Publishing: 135] [Article Influence: 8.4] [Reference Citation Analysis]
132 Li J, Shen W, Liao M, Bartlam M. Preliminary crystallographic analysis of avian infectious bronchitis virus main protease. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007;63:24-6. [PMID: 17183167 DOI: 10.1107/S1744309106052341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
133 Latinne A, Hu B, Olival KJ, Zhu G, Zhang L, Li H, Chmura AA, Field HE, Zambrana-Torrelio C, Epstein JH, Li B, Zhang W, Wang LF, Shi ZL, Daszak P. Origin and cross-species transmission of bat coronaviruses in China. Nat Commun 2020;11:4235. [PMID: 32843626 DOI: 10.1038/s41467-020-17687-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 38.5] [Reference Citation Analysis]
134 Hindawi SI, Hashem AM, Damanhouri GA, El-Kafrawy SA, Tolah AM, Hassan AM, Azhar EI. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light. Transfusion 2018;58:52-9. [PMID: 29239484 DOI: 10.1111/trf.14422] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
135 Carraher CE Jr, Sabir TS, Roner MR, Shahi K, Bleicher RE, Roehr JL, Bassett KD. Synthesis of Organotin Polyamine Ethers Containing Acyclovir and their Preliminary Anticancer and Antiviral Activity. J Inorg Organomet Polym Mater 2006;16:249-57. [PMID: 32214932 DOI: 10.1007/s10904-006-9050-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
136 Mungroo MR, Khan NA, Siddiqui R. The increasing importance of the novel Coronavirus. Hosp Pract (1995) 2021;49:1-11. [PMID: 32990100 DOI: 10.1080/21548331.2020.1828888] [Reference Citation Analysis]
137 Shi Y, Yang DH, Xiong J, Jia J, Huang B, Jin YX. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res. 2005;15:193-200. [PMID: 15780182 DOI: 10.1038/sj.cr.7290286] [Cited by in Crossref: 182] [Cited by in F6Publishing: 122] [Article Influence: 10.7] [Reference Citation Analysis]
138 Gui M, Song W, Zhou H, Xu J, Chen S, Xiang Y, Wang X. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res 2017;27:119-29. [PMID: 28008928 DOI: 10.1038/cr.2016.152] [Cited by in Crossref: 361] [Cited by in F6Publishing: 297] [Article Influence: 60.2] [Reference Citation Analysis]
139 Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004;78:5642-50. [PMID: 15140961 DOI: 10.1128/JVI.78.11.5642-5650.2004] [Cited by in Crossref: 338] [Cited by in F6Publishing: 263] [Article Influence: 18.8] [Reference Citation Analysis]
140 Cheng A, Zhang W, Xie Y, Jiang W, Arnold E, Sarafianos SG, Ding J. Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology 2005;335:165-76. [PMID: 15840516 DOI: 10.1016/j.virol.2005.02.017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
141 Thanigaimalai P, Konno S, Yamamoto T, Koiwai Y, Taguchi A, Takayama K, Yakushiji F, Akaji K, Kiso Y, Kawasaki Y, Chen SE, Naser-Tavakolian A, Schön A, Freire E, Hayashi Y. Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. Eur J Med Chem 2013;65:436-47. [PMID: 23747811 DOI: 10.1016/j.ejmech.2013.05.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
142 Wan J, Sun W, Li X, Ying W, Dai J, Kuai X, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F. Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 2006;6:2886-94. [PMID: 16649161 DOI: 10.1002/pmic.200500638] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
143 Yuan X, Li J, Shan Y, Yang Z, Zhao Z, Chen B, Yao Z, Dong B, Wang S, Chen J, Cong Y. Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Res 2005;109:191-202. [PMID: 15763150 DOI: 10.1016/j.virusres.2005.01.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
144 Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y, Cao S, Wong TY, Lai ST, Xie Y, Guo Z. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 2005;79:3401-8. [PMID: 15731234 DOI: 10.1128/JVI.79.6.3401-3408.2005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
145 Li RL, Chu SG, Luo Y, Huang ZH, Hao Y, Fan CH. Atypical presentation of SARS-CoV-2 infection: A case report. World J Clin Cases 2020; 8(7): 1265-1270 [PMID: 32337201 DOI: 10.12998/wjcc.v8.i7.1265] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
146 Okada M, Okuno Y, Hashimoto S, Kita Y, Kanamaru N, Nishida Y, Tsunai Y, Inoue R, Nakatani H, Fukamizu R, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Kase T, Takemoto Y, Yoshida S, Peiris JS, Chen PJ, Yamamoto N, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine 2007;25:3038-40. [PMID: 17289225 DOI: 10.1016/j.vaccine.2007.01.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
147 Nakagawa K, Makino S. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression. Cells 2021;10:300. [PMID: 33540583 DOI: 10.3390/cells10020300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
148 Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H, Ma S, Chen X, Long B, Si G, Yu H, Yang X, Shi Y, Yang Z. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 2020;93:264-267. [PMID: 32114193 DOI: 10.1016/j.ijid.2020.02.050] [Cited by in Crossref: 189] [Cited by in F6Publishing: 165] [Article Influence: 94.5] [Reference Citation Analysis]
149 Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, Melendez AJ. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 2005;6:2. [PMID: 15655079 DOI: 10.1186/1471-2172-6-2] [Cited by in Crossref: 200] [Cited by in F6Publishing: 1] [Article Influence: 11.8] [Reference Citation Analysis]
150 Van Der Hoek L. Human Coronaviruses: What Do They Cause? Antiviral Therapy 2007;12:651-8. [DOI: 10.1177/135965350701200s01.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
151 Li H, Rothberg L. Colorimetric detection of DNA sequences based on electrostatic interactions with unmodified gold nanoparticles. Proc Natl Acad Sci U S A 2004;101:14036-9. [PMID: 15381774 DOI: 10.1073/pnas.0406115101] [Cited by in Crossref: 993] [Cited by in F6Publishing: 877] [Article Influence: 55.2] [Reference Citation Analysis]
152 Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2003;100:12995-3000. [PMID: 14569023 DOI: 10.1073/pnas.1735582100] [Cited by in Crossref: 264] [Cited by in F6Publishing: 255] [Article Influence: 13.9] [Reference Citation Analysis]
153 Singh A, Thakur M, Sharma LK, Chandra K. Designing a multi-epitope peptide based vaccine against SARS-CoV-2. Sci Rep 2020;10:16219. [PMID: 33004978 DOI: 10.1038/s41598-020-73371-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
154 Chen CJ, Michaelis M, Hsu HK, Tsai CC, Yang KD, Wu YC, Cinatl J Jr, Doerr HW. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol 2008;120:108-11. [PMID: 18762235 DOI: 10.1016/j.jep.2008.07.048] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
155 Amoroso MG, Lucifora G, Degli Uberti B, Serra F, De Luca G, Borriello G, De Domenico A, Brandi S, Cuomo MC, Bove F, Riccardi MG, Galiero G, Fusco G. Fatal Interstitial Pneumonia Associated with Bovine Coronavirus in Cows from Southern Italy. Viruses 2020;12:E1331. [PMID: 33228210 DOI: 10.3390/v12111331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Xie D, Chu H, Yang D, Ding Q, Huang G, Chen L, Cai Z, Huang J, Zhao Z. A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV. J Infect 2021;83:381-412. [PMID: 34216637 DOI: 10.1016/j.jinf.2021.06.020] [Reference Citation Analysis]
157 Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 2004;101:6641-6. [PMID: 15096611 DOI: 10.1073/pnas.0401939101] [Cited by in Crossref: 294] [Cited by in F6Publishing: 285] [Article Influence: 16.3] [Reference Citation Analysis]
158 Zhang C, Liu X, Wang Y, Lu J, Zheng H, Xiong S, Zhang M, Liu Q. Immune responses and histopathological changes in rabbits immunized with inactivated SARS coronavirus. Virol Sin 2007;22:360-5. [DOI: 10.1007/s12250-007-0033-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
159 Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I, Welsch K, Winkler M, Schneider H, Hofmann-Winkler H, Thiel V, Pöhlmann S. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 2013;87:6150-60. [PMID: 23536651 DOI: 10.1128/JVI.03372-12] [Cited by in Crossref: 175] [Cited by in F6Publishing: 127] [Article Influence: 19.4] [Reference Citation Analysis]
160 Wang L, Fu S, Cao Y, Zhang H, Feng Y, Yang W, Nie K, Ma X, Liang G. Discovery and genetic analysis of novel coronaviruses in least horseshoe bats in southwestern China. Emerg Microbes Infect 2017;6:e14. [PMID: 28352124 DOI: 10.1038/emi.2016.140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
161 Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Global Health 2017;13:9. [PMID: 28179007 DOI: 10.1186/s12992-017-0233-9] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 17.6] [Reference Citation Analysis]
162 Widera M, Westhaus S, Rabenau HF, Hoehl S, Bojkova D, Cinatl J Jr, Ciesek S. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. Med Microbiol Immunol 2021;210:235-44. [PMID: 34196781 DOI: 10.1007/s00430-021-00716-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C, Alcaraz A, Torres J, Aguilella VM, Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog 2014;10:e1004077. [PMID: 24788150 DOI: 10.1371/journal.ppat.1004077] [Cited by in Crossref: 230] [Cited by in F6Publishing: 203] [Article Influence: 28.8] [Reference Citation Analysis]
164 Tan TT, Tan BH, Kurup A, Oon LL, Heng D, Thoe SY, Bai XL, Chan KP, Ling AE. Atypical SARS and Escherichia coli bacteremia. Emerg Infect Dis 2004;10:349-52. [PMID: 15030711 DOI: 10.3201/eid1002.030501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
165 Guo H, Hu B, Si HR, Zhu Y, Zhang W, Li B, Li A, Geng R, Lin HF, Yang XL, Zhou P, Shi ZL. Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor. Emerg Microbes Infect 2021;10:1507-14. [PMID: 34263709 DOI: 10.1080/22221751.2021.1956373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Sloots TP, Whiley DM, Lambert SB, Nissen MD. Emerging respiratory agents: new viruses for old diseases? J Clin Virol 2008;42:233-43. [PMID: 18406664 DOI: 10.1016/j.jcv.2008.03.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
167 Hu H, Lu X, Tao L, Bai B, Zhang Z, Chen Y, Zheng F, Chen J, Chen Z, Wang H. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clin Vaccine Immunol 2007;14:894-901. [PMID: 17494640 DOI: 10.1128/CVI.00019-07] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
168 Galán C, Sola I, Nogales A, Thomas B, Akoulitchev A, Enjuanes L, Almazán F. Host cell proteins interacting with the 3' end of TGEV coronavirus genome influence virus replication. Virology 2009;391:304-14. [PMID: 19580983 DOI: 10.1016/j.virol.2009.06.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
169 Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80:5927-5940. [PMID: 16731931 DOI: 10.1128/jvi.02501-05] [Cited by in Crossref: 316] [Cited by in F6Publishing: 246] [Article Influence: 19.8] [Reference Citation Analysis]
170 Ricagno S, Coutard B, Grisel S, Brémond N, Dalle K, Tocque F, Campanacci V, Lichière J, Lantez V, Debarnot C, Cambillau C, Canard B, Egloff MP. Crystallization and preliminary X-ray diffraction analysis of Nsp15 from SARS coronavirus. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006;62:409-11. [PMID: 16582498 DOI: 10.1107/S1744309106009407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
171 Liu HL, Lin JC, Ho Y, Hsieh WC, Chen CW, Su YC. Homology Models and Molecular Dynamics Simulations of Main Proteinase from Coronavirus Associated with Severe Acute Respiratory Syndrome (SARS). J Chin Chem Soc 2004;51:889-900. [PMID: 32336761 DOI: 10.1002/jccs.200400134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
172 Keightley MC, Sillekens P, Schippers W, Rinaldo C, George KS. Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR. J Med Virol 2005;77:602-8. [PMID: 16254971 DOI: 10.1002/jmv.20498] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
173 Qian Z, Dominguez SR, Holmes KV. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One 2013;8:e76469. [PMID: 24098509 DOI: 10.1371/journal.pone.0076469] [Cited by in Crossref: 156] [Cited by in F6Publishing: 141] [Article Influence: 17.3] [Reference Citation Analysis]
174 Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med 2021;23:e3303. [PMID: 33305456 DOI: 10.1002/jgm.3303] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
175 Stavrinides J, Guttman DS. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol 2004;78:76-82. [PMID: 14671089 DOI: 10.1128/jvi.78.1.76-82.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
176 da Silva Santos PS, da Fonseca Orcina B, Machado RRG, Vilhena FV, da Costa Alves LM, Zangrando MSR, de Oliveira RC, Soares MQS, Simão ANC, Pietro ECIN, Kuroda JPG, de Almeida Benjamim IA, Araujo DB, Toma SH, Flor L, Araki K, Durigon EL. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Sci Rep 2021;11:19937. [PMID: 34620904 DOI: 10.1038/s41598-021-99013-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7. [PMID: 15141377 DOI: 10.1002/path.1570] [Reference Citation Analysis]
178 Zhang Y, Li T, Fu L, Yu C, Li Y, Xu X, Wang Y, Ning H, Zhang S, Chen W. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett. 2004;560:141-146. [PMID: 14988013 DOI: 10.1016/s0014-5793(04)00087-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
179 Charitos IA, Del Prete R, Inchingolo F, Mosca A, Carretta D, Ballini A, Santacroce L. What we have learned for the future about COVID-19 and healthcare management of it? Acta Biomed 2020;91:e2020126. [PMID: 33525232 DOI: 10.23750/abm.v91i4.10253] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
180 Ning Q, Yan WM, Wang ZM, Xi D, Liu MF, Levy G, Luo XP. Domain I of nucleocapsid protein of murine hepatitis virus strain 3 upregulates transcription of mfgl2 prothrimbinase/fibroleukin gene. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 594-599 [DOI: 10.11569/wcjd.v12.i3.594] [Reference Citation Analysis]
181 Lee TW, Cherney MM, Huitema C, Liu J, James KE, Powers JC, Eltis LD, James MN. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J Mol Biol 2005;353:1137-51. [PMID: 16219322 DOI: 10.1016/j.jmb.2005.09.004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 6.2] [Reference Citation Analysis]
182 McCallum M, Walls AC, Bowen JE, Corti D, Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat Struct Mol Biol 2020;27:942-9. [PMID: 32753755 DOI: 10.1038/s41594-020-0483-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 31.0] [Reference Citation Analysis]
183 Yin L, Mou H, Shao J, Zhu Y, Pang X, Yang J, Zhang J, Shi W, Yu S, Wang H. Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study. PLoS One 2020;15:e0231687. [PMID: 32348339 DOI: 10.1371/journal.pone.0231687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
184 Chang GH, Dividson A, Lin L, Wilson M, Siddell SG, Zhu QY. Establishment of the eukaryotic cell lines for inducible control of SARS-CoV nucleocapsid gene expression. Virol Sin 2010;25:361-8. [PMID: 20960182 DOI: 10.1007/s12250-010-3124-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
185 Baildya N, Ghosh NN, Chattopadhyay AP, Mandal V, Majumdar S, Ansary D, Sarkar MM. Inhibitory effect of compounds extracted from Monochoria hastata (L.) Solms on SARS-CoV-2 main protease: An insight from molecular docking and MD-simulation studies. J Mol Struct 2022;1257:132644. [PMID: 35185220 DOI: 10.1016/j.molstruc.2022.132644] [Reference Citation Analysis]
186 Deng K, Li H, Ma X, Yu B, Yi X, Chen Y, Tian B, Zhang Q. Analysis of the positive rate of 4254 cases of COVID-19 nucleic acid tests in different aites in Wuhan, China. J Med Virol 2021;93:870-7. [PMID: 32691919 DOI: 10.1002/jmv.26323] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med. 2020;41:568-578. [PMID: 32305045 DOI: 10.1055/s-0040-1709160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
188 Zhang CY, Wei JF, He SH. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. BMC Microbiol 2006;6:88. [PMID: 17020602 DOI: 10.1186/1471-2180-6-88] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
189 Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006;38:38-46. [PMID: 16369534 DOI: 10.1038/ng1698] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 5.8] [Reference Citation Analysis]
190 Bartlam M, Yang H, Rao Z. Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol 2005;15:664-72. [PMID: 16263266 DOI: 10.1016/j.sbi.2005.10.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]
191 Wasiluk T, Rogowska A, Boczkowska-Radziwon B, Zebrowska A, Bolkun L, Piszcz J, Radziwon P. Maintaining plasma quality and safety in the state of ongoing epidemic - The role of pathogen reduction. Transfus Apher Sci 2021;60:102953. [PMID: 33023853 DOI: 10.1016/j.transci.2020.102953] [Reference Citation Analysis]
192 Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Front Immunol 2020;11:1979. [PMID: 32973803 DOI: 10.3389/fimmu.2020.01979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
193 Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol 2015;89:2995-3007. [PMID: 25520500 DOI: 10.1128/JVI.02980-14] [Cited by in Crossref: 117] [Cited by in F6Publishing: 80] [Article Influence: 14.6] [Reference Citation Analysis]
194 Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 2014;5:3067. [PMID: 24473083 DOI: 10.1038/ncomms4067] [Cited by in Crossref: 196] [Cited by in F6Publishing: 204] [Article Influence: 28.0] [Reference Citation Analysis]
195 Yuan X, Shan Y, Zhao Z, Chen J, Cong Y. G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol J 2005;2:66. [PMID: 16107218 DOI: 10.1186/1743-422X-2-66] [Cited by in Crossref: 84] [Article Influence: 4.9] [Reference Citation Analysis]
196 Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Mol Ther 2004;10:616-29. [PMID: 15451446 DOI: 10.1016/j.ymthe.2004.07.013] [Cited by in Crossref: 361] [Cited by in F6Publishing: 348] [Article Influence: 21.2] [Reference Citation Analysis]
197 Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents. Bioorg Med Chem Lett 2018;28:3472-6. [PMID: 30286952 DOI: 10.1016/j.bmcl.2018.09.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
198 AlBalwi MA, Khan A, AlDrees M, Gk U, Manie B, Arabi Y, Alabdulkareem I, AlJohani S, Alghoribi M, AlAskar A, AlAjlan A, Hajeer A. Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). J Infect Public Health 2020;13:1544-50. [PMID: 32654959 DOI: 10.1016/j.jiph.2020.06.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
199 Chang Z, Hu Z. RNAi therapeutics: can siRNAs conquer SARS? Gene Ther 2006;13:871-2. [PMID: 17262907 DOI: 10.1038/sj.gt.3302682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
200 Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112-116. [PMID: 16001071 DOI: 10.1038/nature03712] [Cited by in Crossref: 1473] [Cited by in F6Publishing: 1350] [Article Influence: 86.6] [Reference Citation Analysis]
201 Wallin R, van Iersel L, Kelk S, Stougie L. Applicability of several rooted phylogenetic network algorithms for representing the evolutionary history of SARS-CoV-2. BMC Ecol Evol 2021;21:220. [PMID: 34876022 DOI: 10.1186/s12862-021-01946-y] [Reference Citation Analysis]
202 Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704. [PMID: 15838797 DOI: 10.1086/429631] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 9.7] [Reference Citation Analysis]
203 Liu IJ, Chen PJ, Yeh SH, Chiang YP, Huang LM, Chang MF, Chen SY, Yang PC, Chang SC, Wang WK; SARS Research Group of the National Taiwan University College of Medicine-National Taiwan University Hospital. Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. J Clin Microbiol 2005;43:2444-8. [PMID: 15872279 DOI: 10.1128/JCM.43.5.2444-2448.2005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
204 Zou W, Xiong M, Hao S, Zhang EY, Baumlin N, Kim MD, Salathe M, Yan Z, Qiu J. The SARS-CoV-2 Transcriptome and the Dynamics of the S Gene Furin Cleavage Site in Primary Human Airway Epithelia. mBio 2021;12:e01006-21. [PMID: 33975939 DOI: 10.1128/mBio.01006-21] [Reference Citation Analysis]
205 Cho CH, Chulten B, Lee CK, Nam MH, Yoon SY, Lim CS, Cho Y, Kim YK. Evaluation of a novel real-time RT-PCR using TOCE technology compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses. J Clin Virol 2013;57:338-42. [PMID: 23743345 DOI: 10.1016/j.jcv.2013.04.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
206 Liu L, Hu J, Hou Y, Tao Z, Chen Z, Chen K. Pit latrines may be a potential risk in rural China and low-income countries when dealing with COVID-19. Sci Total Environ 2021;761:143283. [PMID: 33162149 DOI: 10.1016/j.scitotenv.2020.143283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
207 Junglen S, Drosten C. Virus discovery and recent insights into virus diversity in arthropods. Curr Opin Microbiol 2013;16:507-13. [PMID: 23850098 DOI: 10.1016/j.mib.2013.06.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 7.2] [Reference Citation Analysis]
208 Kin N, Vabret A. [New therapies against HCV]. Rev Francoph Lab 2016;2016:25-33. [PMID: 32288826 DOI: 10.1016/S1773-035X(16)30369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
209 Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J Virol 2006;80:10315-24. [PMID: 17041212 DOI: 10.1128/JVI.01138-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
210 Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, Zhu Y, Hedenstierna G, Wang CG. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis 2004;39:1531-5. [PMID: 15546092 DOI: 10.1086/425357] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
211 Yu M, Zhang T, Zhang W, Sun Q, Li H, Li JP. Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic. Front Mol Biosci 2020;7:628551. [PMID: 33569392 DOI: 10.3389/fmolb.2020.628551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
212 Robinson CA, Hsieh HY, Hsu SY, Wang Y, Salcedo BT, Belenchia A, Klutts J, Zemmer S, Reynolds M, Semkiw E, Foley T, Wan X, Wieberg CG, Wenzel J, Lin CH, Johnson MC. Defining biological and biophysical properties of SARS-CoV-2 genetic material in wastewater. Sci Total Environ 2022;807:150786. [PMID: 34619200 DOI: 10.1016/j.scitotenv.2021.150786] [Reference Citation Analysis]
213 Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne) 2021;8:640073. [PMID: 33681266 DOI: 10.3389/fmed.2021.640073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
214 Khadadah M, Essa S, Higazi Z, Behbehani N, Al-Nakib W. Respiratory syncytial virus and human rhinoviruses are the major causes of severe lower respiratory tract infections in Kuwait. J Med Virol 2010;82:1462-7. [PMID: 20572084 DOI: 10.1002/jmv.21823] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
215 Lednicky JA, Waltzek TB, McGeehan E, Loeb JC, Hamilton SB, Luetke MC. Isolation and genetic characterization of human coronavirus NL63 in primary human renal proximal tubular epithelial cells obtained from a commercial supplier, and confirmation of its replication in two different types of human primary kidney cells. Virol J 2013;10:213. [PMID: 23805916 DOI: 10.1186/1743-422X-10-213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
216 Andrabi MS, Andrabi SA. Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019. Front Pharmacol 2020;11:570031. [PMID: 33613275 DOI: 10.3389/fphar.2020.570031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
217 Adu-Agyeiwaah Y, Grant MB, Obukhov AG. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes. Cells 2020;9:E2528. [PMID: 33238570 DOI: 10.3390/cells9112528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
218 Kumar S, Chauhan R, Kumar M. Sensitivity Enhancement of Dual Gate FET Based Biosensor Using Modulated Dielectric for Covid Detection. Silicon. [DOI: 10.1007/s12633-022-01865-7] [Reference Citation Analysis]
219 Attia MA, Essa EA, Elebyary TT, Faheem AM, Elkordy AA. Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines. Pharmaceuticals (Basel) 2021;14:1173. [PMID: 34832955 DOI: 10.3390/ph14111173] [Reference Citation Analysis]
220 Pérez-Cataluña A, Chiner-Oms Á, Cuevas-Ferrando E, Díaz-Reolid A, Falcó I, Randazzo W, Girón-Guzmán I, Allende A, Bracho MA, Comas I, Sánchez G. Spatial and temporal distribution of SARS-CoV-2 diversity circulating in wastewater. Water Res 2021;211:118007. [PMID: 35033744 DOI: 10.1016/j.watres.2021.118007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
221 Han SH, Goins CM, Arya T, Shin WJ, Maw J, Hooper A, Sonawane DP, Porter MR, Bannister BE, Crouch RD, Lindsey AA, Lakatos G, Martinez SR, Alvarado J, Akers WS, Wang NS, Jung JU, Macdonald JD, Stauffer SR. Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro). J Med Chem 2021. [PMID: 34347470 DOI: 10.1021/acs.jmedchem.1c00598] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
222 Li FQ, Xiao H, Tam JP, Liu DX. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus. FEBS Lett 2005;579:2387-96. [PMID: 15848177 DOI: 10.1016/j.febslet.2005.03.039] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
223 Mazzariol A, Benini A, Unali I, Nocini R, Smania M, Bertoncelli A, De Sanctis F, Ugel S, Donadello K, Polati E, Gibellini D. Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation. Front Cell Infect Microbiol 2021;11:683409. [PMID: 34458159 DOI: 10.3389/fcimb.2021.683409] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Chen SY, Chiang WC, Ma MH, Su CP, Hsu CY, Ko PC, Tsai KC, Yen ZS, Shih FY, Chen SC, Lin SJ, Wang JL, Chang SC, Chen WJ. Sequential symptomatic analysis in probable severe acute respiratory syndrome cases. Ann Emerg Med 2004;43:27-33. [PMID: 14707937 DOI: 10.1016/j.annemergmed.2003.10.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
225 Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton OJ, Bowen JE, Wang C, Xiong X, de van der Schueren W, Quispe J, Hoffstrom BG, Bosch BJ, McGuire AT, Veesler D. Structural basis for broad coronavirus neutralization. Nat Struct Mol Biol 2021;28:478-86. [PMID: 33981021 DOI: 10.1038/s41594-021-00596-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
226 Roh C. A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int J Nanomedicine 2012;7:2173-9. [PMID: 22619553 DOI: 10.2147/IJN.S31379] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
227 Altimier L, Seiver A. The 2020 COVID-19 pandemic. J Neonatal Nurs 2020;26:183-91. [PMID: 32834732 DOI: 10.1016/j.jnn.2020.06.002] [Reference Citation Analysis]
228 Milewska A, Ciejka J, Kaminski K, Karewicz A, Bielska D, Zeglen S, Karolak W, Nowakowska M, Potempa J, Bosch BJ, Pyrc K, Szczubialka K. Novel polymeric inhibitors of HCoV-NL63. Antiviral Res 2013;97:112-21. [PMID: 23201315 DOI: 10.1016/j.antiviral.2012.11.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
229 Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE, Martin ET, Petrie JG. Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan. J Infect Dis 2020;222:9-16. [PMID: 32246136 DOI: 10.1093/infdis/jiaa161] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 33.0] [Reference Citation Analysis]
230 de Vlas SJ, Cao WC, Richardus JH. Documenting the SARS epidemic in mainland China. Trop Med Int Health 2009;14 Suppl 1:1-3. [PMID: 19814760 DOI: 10.1111/j.1365-3156.2009.02349.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
231 Widera M, Wilhelm A, Toptan T, Raffel JM, Kowarz E, Roesmann F, Grözinger F, Siemund AL, Luciano V, Külp M, Reis J, Bracharz S, Pallas C, Ciesek S, Marschalek R. Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication. Front Microbiol 2021;12:701198. [PMID: 34394046 DOI: 10.3389/fmicb.2021.701198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Hussain S, Baxi H, Chand Jamali M, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence. Diabetes Metab Syndr 2020;14:1595-602. [PMID: 32862098 DOI: 10.1016/j.dsx.2020.08.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
233 Wang G, Liang R, Liu Z, Shen Z, Shi J, Shi Y, Deng F, Xiao S, Fu ZF, Peng G. The N-Terminal Domain of Spike Protein Is Not the Enteric Tropism Determinant for Transmissible Gastroenteritis Virus in Piglets. Viruses 2019;11:E313. [PMID: 30935078 DOI: 10.3390/v11040313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
234 Hu T, Zhang Y, Li L, Wang K, Chen S, Chen J, Ding J, Jiang H, Shen X. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 2009;388:324-34. [PMID: 19409595 DOI: 10.1016/j.virol.2009.03.034] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
235 Holbrook MG, Anthony SJ, Navarrete-Macias I, Bestebroer T, Munster VJ, van Doremalen N. Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera. Viruses 2021;13:599. [PMID: 33915875 DOI: 10.3390/v13040599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Tang X, Li G, Vasilakis N, Zhang Y, Shi Z, Zhong Y, Wang LF, Zhang S. Differential stepwise evolution of SARS coronavirus functional proteins in different host species. BMC Evol Biol 2009;9:52. [PMID: 19261195 DOI: 10.1186/1471-2148-9-52] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
237 Wong RS, Hui DS. Index patient and SARS outbreak in Hong Kong. Emerg Infect Dis 2004;10:339-41. [PMID: 15030708 DOI: 10.3201/eid1002.030645] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
238 Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramírez-Vallejo E, Suárez JA, Zambrano LI, Villamil-Gómez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. [PMID: 32179124 DOI: 10.1016/j.tmaid.2020.101623] [Cited by in Crossref: 970] [Cited by in F6Publishing: 796] [Article Influence: 485.0] [Reference Citation Analysis]
239 Woo PC, Lau SK, Tsoi HW, Chan KH, Wong BH, Che XY, Tam VK, Tam SC, Cheng VC, Hung IF, Wong SS, Zheng BJ, Guan Y, Yuen KY. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004;363:841-5. [PMID: 15031027 DOI: 10.1016/S0140-6736(04)15729-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 5.7] [Reference Citation Analysis]
240 van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, Petersen G, Forster J, Berkhout B, Uberla K. Human coronavirus NL63 infection is associated with croup. Adv Exp Med Biol 2006;581:485-91. [PMID: 17037582 DOI: 10.1007/978-0-387-33012-9_86] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
241 Pyrc K, Stożek K, Galan W, Potempa J. HexaPrime: a novel method for detection of coronaviruses. J Virol Methods 2013;188:29-36. [PMID: 23219933 DOI: 10.1016/j.jviromet.2012.11.039] [Reference Citation Analysis]
242 Albahri AS, Hamid RA, Alwan JK, Al-Qays ZT, Zaidan AA, Zaidan BB, Albahri AOS, AlAmoodi AH, Khlaf JM, Almahdi EM, Thabet E, Hadi SM, Mohammed KI, Alsalem MA, Al-Obaidi JR, Madhloom HT. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. J Med Syst 2020;44:122. [PMID: 32451808 DOI: 10.1007/s10916-020-01582-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 38] [Article Influence: 32.0] [Reference Citation Analysis]
243 Xie XP, Sheng LP, Han CQ, Jin Y, Bai T, Lin R, Ding Z, Hou XH. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: A prospective observational study. J Med Virol 2022;94:246-52. [PMID: 34460118 DOI: 10.1002/jmv.27308] [Reference Citation Analysis]
244 Martinez MA. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrob Agents Chemother 2020;64:e00399-20. [PMID: 32152082 DOI: 10.1128/AAC.00399-20] [Cited by in Crossref: 199] [Cited by in F6Publishing: 154] [Article Influence: 99.5] [Reference Citation Analysis]
245 Huang JL, Lin HT, Wang YM, Weng MH, Ji DD, Kuo MD, Liu HW, Lin CS. Sensitive and specific detection of strains of Japanese encephalitis virus using a one-step TaqMan RT-PCR technique. J Med Virol 2004;74:589-96. [PMID: 15484282 DOI: 10.1002/jmv.20218] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
246 Dutta NK, Mazumdar K, Lee BH, Baek MW, Kim DJ, Na YR, Park SH, Lee HK, Kariwa H, Mai le Q, Park JH. Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine. Immunol Lett 2008;118:65-71. [PMID: 18440652 DOI: 10.1016/j.imlet.2008.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
247 Turner BC, Hemmila EM, Beauchemin N, Holmes KV. Receptor-dependent coronavirus infection of dendritic cells. J Virol 2004;78:5486-90. [PMID: 15113927 DOI: 10.1128/jvi.78.10.5486-5490.2004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
248 Xie Q, He X, Yang F, Liu X, Li Y, Liu Y, Yang Z, Yu J, Zhang B, Zhao W. Analysis of the Genome Sequence and Prediction of B-Cell Epitopes of the Envelope Protein of Middle East Respiratory Syndrome-Coronavirus. IEEE/ACM Trans Comput Biol Bioinform 2018;15:1344-50. [PMID: 28574363 DOI: 10.1109/TCBB.2017.2702588] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
249 Spencer Q. Do Newton’s rules of reasoning guarantee truth … must they? Studies in History and Philosophy of Science Part A 2004;35:759-82. [DOI: 10.1016/j.shpsa.2004.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
250 Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 2007;81:1848-57. [PMID: 17151094 DOI: 10.1128/JVI.01967-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
251 Li YH, Li J, Liu XE, Wang L, Li T, Zhou YH, Zhuang H. Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers. J Virol Methods 2005;130:45-50. [PMID: 16024098 DOI: 10.1016/j.jviromet.2005.06.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
252 Yang LT, Peng H, Zhu ZL, Li G, Huang ZT, Zhao ZX, Koup RA, Bailer RT, Wu CY. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin Immunol. 2006;120:171-178. [PMID: 16781892 DOI: 10.1016/j.clim.2006.05.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
253 Abdullah AS, Tomlinson B, Cockram CS, Thomas GN. Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 2003;9:1042-5. [PMID: 14519237 DOI: 10.3201/eid0909.030366] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
254 Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, Koup RA, Bailer RT, Wu CY. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006;351:466-75. [PMID: 16690096 DOI: 10.1016/j.virol.2006.03.036] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
255 Alvarez E, DeDiego ML, Nieto-Torres JL, Jiménez-Guardeño JM, Marcos-Villar L, Enjuanes L. The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated. Virology 2010;402:281-91. [PMID: 20409569 DOI: 10.1016/j.virol.2010.03.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
256 Wu XD, Shang B, Yang RF, Yu H, Ma ZH, Shen X, Ji YY, Lin Y, Wu YD, Lin GM, Tian L, Gan XQ, Yang S, Jiang WH, Dai EH, Wang XY, Jiang HL, Xie YH, Zhu XL, Pei G, Li L, Wu JR, Sun B. The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. Cell Res 2004;14:400-6. [PMID: 15450134 DOI: 10.1038/sj.cr.7290240] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
257 Cai Y, Jiam NT, Wai KC, Shuman EA, Roland LT, Chang JL. Otolaryngology Resident Practices and Perceptions in the Initial Phase of the U.S. COVID-19 Pandemic. Laryngoscope 2020;130:2550-7. [PMID: 32368800 DOI: 10.1002/lary.28733] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
258 Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Pharmaceuticals (Basel) 2020;13:E166. [PMID: 32722596 DOI: 10.3390/ph13080166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
259 Roberts A, Wood J, Subbarao K, Ferguson M, Wood D, Cherian T. Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. Vaccine 2006;24:7056-65. [PMID: 16930781 DOI: 10.1016/j.vaccine.2006.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
260 Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, Ko FW, Chan MC, Chan DP, Tong MW, Rainer TH, Ahuja AT, Cockram CS, Sung JJ. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005;60:401-9. [PMID: 15860716 DOI: 10.1136/thx.2004.030205] [Cited by in Crossref: 170] [Cited by in F6Publishing: 161] [Article Influence: 10.0] [Reference Citation Analysis]
261 Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021. [PMID: 34727365 DOI: 10.1007/s13365-021-01014-7] [Reference Citation Analysis]
262 Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Cerro Chiang G, Kassar AG, Patel N, Green CER, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. Cell Rep 2021;34:108590. [PMID: 33357411 DOI: 10.1016/j.celrep.2020.108590] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
263 Pachetti M, Marini B, Giudici F, Benedetti F, Angeletti S, Ciccozzi M, Masciovecchio C, Ippodrino R, Zella D. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America. J Transl Med 2020;18:338. [PMID: 32878627 DOI: 10.1186/s12967-020-02501-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
264 Guruprasad L. Human coronavirus spike protein-host receptor recognition. Prog Biophys Mol Biol 2021;161:39-53. [PMID: 33137344 DOI: 10.1016/j.pbiomolbio.2020.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
265 Cui W, Ouyang T, Qiu Y, Cui D. Literature Review of the Implications of Exercise Rehabilitation Strategies for SARS Patients on the Recovery of COVID-19 Patients. Healthcare (Basel) 2021;9:590. [PMID: 34070115 DOI: 10.3390/healthcare9050590] [Reference Citation Analysis]
266 Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 2004;121:85-91. [PMID: 15350737 DOI: 10.1016/j.jviromet.2004.06.006] [Cited by in Crossref: 353] [Cited by in F6Publishing: 266] [Article Influence: 20.8] [Reference Citation Analysis]
267 Lu W, Zheng BJ, Xu K, Schwarz W, Du L, Wong CK, Chen J, Duan S, Deubel V, Sun B. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci U S A 2006;103:12540-5. [PMID: 16894145 DOI: 10.1073/pnas.0605402103] [Cited by in Crossref: 168] [Cited by in F6Publishing: 148] [Article Influence: 10.5] [Reference Citation Analysis]
268 McGruder B, Leibowitz JL. A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis. J Gen Virol 2015;96:494-506. [PMID: 25252685 DOI: 10.1099/vir.0.069732-0] [Reference Citation Analysis]
269 Ghahremanpour MM, Tirado-Rives J, Deshmukh M, Ippolito JA, Zhang CH, Cabeza de Vaca I, Liosi ME, Anderson KS, Jorgensen WL. Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2. ACS Med Chem Lett 2020;11:2526-33. [PMID: 33324471 DOI: 10.1021/acsmedchemlett.0c00521] [Cited by in Crossref: 104] [Cited by in F6Publishing: 78] [Article Influence: 52.0] [Reference Citation Analysis]
270 Dadinaboyina SB, Yerra NV, Adimoolam BM, Parsa S, Bathini NB, Thota JR. Identification and characterization of degradation products of Remdesivir using liquid chromatography/mass spectrometry. New J Chem 2021;45:7217-24. [DOI: 10.1039/d1nj00160d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
271 Unni S, Aouti S, Thiyagarajan S, Padmanabhan B. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods. J Biosci 2020;45:130. [PMID: 33184246 [PMID: 33184246 DOI: 10.1007/s12038-020-00102-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
272 Fernandez-Garcia L, Pacios O, González-Bardanca M, Blasco L, Bleriot I, Ambroa A, López M, Bou G, Tomás M. Viral Related Tools against SARS-CoV-2. Viruses 2020;12:E1172. [PMID: 33081350 DOI: 10.3390/v12101172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2021;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
274 Almansour I, Macadato NC, Alshammari T. Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2. Pharmaceuticals (Basel) 2021;14:39. [PMID: 33419184 DOI: 10.3390/ph14010039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. [PMID: 32364264 DOI: 10.1111/his.14134] [Cited by in Crossref: 493] [Cited by in F6Publishing: 466] [Article Influence: 246.5] [Reference Citation Analysis]
276 Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450-454. [PMID: 14647384 DOI: 10.1038/nature02145] [Cited by in Crossref: 3235] [Cited by in F6Publishing: 2976] [Article Influence: 170.3] [Reference Citation Analysis]
277 Cortes AA, Zuñiga JM. The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review. Diagn Microbiol Infect Dis 2020;98:115176. [PMID: 33069048 DOI: 10.1016/j.diagmicrobio.2020.115176] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
278 Wang ZG, Zheng ZH, Shang L, Li LJ, Cong LM, Feng MG, Luo Y, Cheng SY, Zhang YJ, Ru MG, Wang ZX, Bao QY. Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV. FEBS Lett 2005;579:4928-36. [PMID: 16112670 DOI: 10.1016/j.febslet.2005.07.075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
279 Laperche S. Definition of emerging infectious diseases. ISBT Sci Ser 2011;6:112-5. [PMID: 32328166 DOI: 10.1111/j.1751-2824.2011.01452.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
280 Khazaei S, Bashirian S, Jenabi E, Barati M, Karimi-shahanjarini A, Moeini B, Rezapur-shahkolai F, Karami M, Khazaei M, Hashemi SZ, Ataei A, Eskandari Z, Fazli Z; Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran., Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Modeling for Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran., Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran., Department of Health Education, Vice Chancellor for Health, Hamadan University of Medical Sciences, Hamadan, Iran., Department of Health Education, Vice Chancellor for Health, Hamadan University of Medical Sciences, Hamadan, Iran., Department of Health Education, Vice Chancellor for Health, Hamadan University of Medical Sciences, Hamadan, Iran., Department of Health Education, Vice Chancellor for Health, Hamadan University of Medical Sciences, Hamadan, Iran. COVID-19 Preventive Behaviors and its Related Beliefs among Health Workers: The Role of Threat and Coping Appraisals. J Educ Community Health 2020;7:221-7. [DOI: 10.29252/jech.7.3.221] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
281 Puppe W, Weigl J, Gröndahl B, Knuf M, Rockahr S, von Bismarck P, Aron G, Niesters HG, Osterhaus AD, Schmitt HJ. Validation of a multiplex reverse transcriptase PCR ELISA for the detection of 19 respiratory tract pathogens. Infection 2013;41:77-91. [PMID: 22847627 DOI: 10.1007/s15010-012-0298-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
282 Che XY, Qiu LW, Pan YX, Wen K, Hao W, Zhang LY, Wang YD, Liao ZY, Hua X, Cheng VC, Yuen KY. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol 2004;42:2629-35. [PMID: 15184444 DOI: 10.1128/JCM.42.6.2629-2635.2004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
283 Shi Y, Wang G, Cai XP, Deng JW, Zheng L, Zhu HH, Zheng M, Yang B, Chen Z. An overview of COVID-19. J Zhejiang Univ Sci B 2020;21:343-60. [PMID: 32425000 DOI: 10.1631/jzus.B2000083] [Cited by in Crossref: 85] [Cited by in F6Publishing: 44] [Article Influence: 42.5] [Reference Citation Analysis]
284 Chen CZ, Xu M, Pradhan M, Gorshkov K, Petersen JD, Straus MR, Zhu W, Shinn P, Guo H, Shen M, Klumpp-Thomas C, Michael SG, Zimmerberg J, Zheng W, Whittaker GR. Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles. ACS Pharmacol Transl Sci 2020;3:1165-75. [PMID: 33330839 DOI: 10.1021/acsptsci.0c00112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
285 Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265-269. [PMID: 32015508 DOI: 10.1038/s41586-020-2008-3] [Cited by in Crossref: 4589] [Cited by in F6Publishing: 3642] [Article Influence: 2294.5] [Reference Citation Analysis]
286 Dara SI, Farmer JC. Preparedness lessons from modern disasters and wars. Crit Care Clin 2009;25:47-65, vii. [PMID: 19268794 DOI: 10.1016/j.ccc.2008.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
287 Nomura R, Kiyota A, Suzaki E, Kataoka K, Ohe Y, Miyamoto K, Senda T, Fujimoto T. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J Virol 2004;78:8701-8. [PMID: 15280478 DOI: 10.1128/JVI.78.16.8701-8708.2004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 6.5] [Reference Citation Analysis]
288 Wei WI, Ho WK. Severe acute respiratory syndrome: what have we learned. Adv Surg 2005;39:343-54. [PMID: 16250560 DOI: 10.1016/j.yasu.2005.04.001] [Reference Citation Analysis]
289 Akaji K, Konno H, Onozuka M, Makino A, Saito H, Nosaka K. Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant. Bioorg Med Chem 2008;16:9400-8. [PMID: 18845442 DOI: 10.1016/j.bmc.2008.09.057] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
290 Ahn JG, Choi SY, Kim DS, Kim KH. Human bocavirus isolated from children with acute respiratory tract infections in Korea, 2010-2011. J Med Virol 2014;86:2011-8. [PMID: 24390980 DOI: 10.1002/jmv.23880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
291 Chen HI. Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations. J Geriatr Cardiol 2011;8:44-54. [PMID: 22783284 DOI: 10.3724/SP.J.1263.2011.00044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
292 Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191:193-197. [PMID: 15609228 DOI: 10.1086/426870] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
293 Ng OW, Keng CT, Leung CS, Peiris JS, Poon LL, Tan YJ. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody. PLoS One 2014;9:e102415. [PMID: 25019613 DOI: 10.1371/journal.pone.0102415] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
294 Möller S, Theiß J, Deinert TIL, Golat K, Heinze J, Niemeyer D, Wyrwa R, Schnabelrauch M, Bogner E. High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication. Viruses 2022;14:413. [DOI: 10.3390/v14020413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
295 Hozhabri H, Piceci Sparascio F, Sohrabi H, Mousavifar L, Roy R, Scribano D, De Luca A, Ambrosi C, Sarshar M. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting. Int J Environ Res Public Health 2020;17:E5648. [PMID: 32764417 DOI: 10.3390/ijerph17165648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
296 Xiao S, Tian Z, Wang Y, Si L, Zhang L, Zhou D. Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives. Med Res Rev 2018;38:951-76. [PMID: 29350407 DOI: 10.1002/med.21484] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 15.5] [Reference Citation Analysis]
297 Chu LH, Choy WY, Tsai SN, Rao Z, Ngai SM. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 2006;15:699-709. [PMID: 16600962 DOI: 10.1110/ps.052007306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
298 Arasu A, Balakrishnan P, Velusamy T, Ramesh T. Can Mandated BCG Vaccine Promote herd Immunity against Novel Coronavirus? A Potential Solution at Hand to Tackle Covid-19 Pandemic. CIR 2020;16:6-11. [DOI: 10.2174/1573395516999201112092557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Principi N, Bosis S, Esposito S. Effects of coronavirus infections in children. Emerg Infect Dis 2010;16:183-8. [PMID: 20113545 DOI: 10.3201/eid1602.090469] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
300 Eckerle I, Lenk M, Ulrich RG. More novel hantaviruses and diversifying reservoir hosts--time for development of reservoir-derived cell culture models? Viruses 2014;6:951-67. [PMID: 24576845 DOI: 10.3390/v6030951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
301 Huang C, Peters CJ, Makino S. Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J Virol 2007;81:5423-6. [PMID: 17344286 DOI: 10.1128/JVI.02307-06] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
302 Morris JG Jr, Greenspan A, Howell K, Gargano LM, Mitchell J, Jones JL, Potter M, Isakov A, Woods C, Hughes JM. Southeastern Center for Emerging Biologic Threats tabletop exercise: foodborne toxoplasmosis outbreak on college campuses. Biosecur Bioterror 2012;10:89-97. [PMID: 22283568 DOI: 10.1089/bsp.2011.0040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
303 Milne-Price S, Miazgowicz KL, Munster VJ. The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis 2014;71:121-36. [PMID: 24585737 DOI: 10.1111/2049-632X.12166] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
304 Nie Q, Li X, Chen W, Liu D, Chen Y, Li H, Li D, Tian M, Tan W, Zai J. Phylogenetic and phylodynamic analyses of SARS-CoV-2. Virus Res 2020;287:198098. [PMID: 32687861 DOI: 10.1016/j.virusres.2020.198098] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 24.0] [Reference Citation Analysis]
305 Jamieson AM. Host resilience to emerging coronaviruses. Future Virol 2016;11:529-34. [PMID: 32201496 DOI: 10.2217/fvl-2016-0060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
306 Shinoda S; Collaborative Research Center for Infectious Diseases in India, Okayama University Tsushima-naka, Okayama, Okayama 700-8530, Japan. COVID-19 and Spanish Flu, the Representative Pandemics of the 21st and 20th Centuries. JDR 2022;17:65-72. [DOI: 10.20965/jdr.2022.p0065] [Reference Citation Analysis]
307 Wang Q, Li L, Qu T, Li J, Wu L, Li K, Wang Z, Zhu M, Huang B, Wu W, Wu M, Ding R, Zhang Z, Wang Q, Xia X, Li P, Zhang Z, Guo R. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Front Oncol 2021;11:644575. [PMID: 34094930 DOI: 10.3389/fonc.2021.644575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
308 Zhang Z, Xu D, Li Y, Jin L, Shi M, Wang M, Zhou X, Wu H, Gao GF, Wang FS. Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clin Immunol 2005;116:225-35. [PMID: 15964242 DOI: 10.1016/j.clim.2005.04.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
309 Imre G. Cell death signalling in virus infection. Cell Signal 2020;76:109772. [PMID: 32931899 DOI: 10.1016/j.cellsig.2020.109772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
310 Geller C, Fontanay S, Finance C, Duval RE. A new Sephadex-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model. J Virol Methods. 2009;159:217-226. [PMID: 19490977 DOI: 10.1016/j.jviromet.2009.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
311 Jernigan JA, Low DE, Hefland RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004;10:327-33. [PMID: 15030706 DOI: 10.3201/eid1002.030741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
312 Yi WL, Fang F, Ning Q, Shu SN, Li G. Preventive and therapeutic effects of Shuanghuanglian and allitride against experimental murine hepatitis virus type 3 infection in vivoShijie Huaren Xiaohua Zazhi 2011; 19(22): 2316-2321 [DOI: 10.11569/wcjd.v19.i22.2316] [Reference Citation Analysis]
313 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
314 Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment. Int J Mol Sci 2020;21:E3377. [PMID: 32397684 DOI: 10.3390/ijms21093377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Tan J, Verschueren KH, Anand K, Shen J, Yang M, Xu Y, Rao Z, Bigalke J, Heisen B, Mesters JR, Chen K, Shen X, Jiang H, Hilgenfeld R. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol 2005;354:25-40. [PMID: 16242152 DOI: 10.1016/j.jmb.2005.09.012] [Cited by in Crossref: 104] [Cited by in F6Publishing: 93] [Article Influence: 6.1] [Reference Citation Analysis]
316 Deshwal V, Kumar V. Study of Coronavirus Disease (COVID-19) Outbreak in India. TONURSJ 2021;15:62-73. [DOI: 10.2174/1874434602115010062] [Reference Citation Analysis]
317 Yi L, Li Z, Yuan K, Qu X, Chen J, Wang G, Zhang H, Luo H, Zhu L, Jiang P, Chen L, Shen Y, Luo M, Zuo G, Hu J, Duan D, Nie Y, Shi X, Wang W, Han Y, Li T, Liu Y, Ding M, Deng H, Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol 2004;78:11334-9. [PMID: 15452254 DOI: 10.1128/JVI.78.20.11334-11339.2004] [Cited by in Crossref: 181] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
318 Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620-2629. [PMID: 32217835 DOI: 10.1172/jci137244] [Cited by in Crossref: 1925] [Cited by in F6Publishing: 1406] [Article Influence: 962.5] [Reference Citation Analysis]
319 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Clinical features of probable severe acute respiratory syndrome in Beijing. World J Gastroenterol 2005; 11(19): 2971-2974 [PMID: 15902739 DOI: 10.3748/wjg.v11.i19.2971] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
320 Cui HJ, Tong XL, Li P, Hao YX, Chen XG, Li AG, Zhang ZY, Duan J, Zhen M, Zhang B, Hua CJ, Gong YW. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis. World J Gastroenterol 2004; 10(11): 1652-1655 [PMID: 15162543 DOI: 10.3748/wjg.v10.i11.1652] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
321 Leung KK, Zhang R, Hashim MJ, Fang M, Xu J, Sun D, Li X, Liu Y, Deng H, Zeng D, Lin Z, He P, Zhang Y, Zhu X, Liang D, Xing A, Lee S, Memish ZA, Jiang G, Khan G. Effectiveness of containment strategies in preventing SARS-CoV-2 transmission. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.04.012] [Reference Citation Analysis]
322 Finkbeiner S, Wang D. New Virus Discovery in the 21st Century. In: Persing DH, Tenover FC, Tang Y, Nolle FS, Hayden RT, van Belkum A, editors. Molecular Microbiology. Wiley; 2011. pp. 641-52. [DOI: 10.1128/9781555816834.ch41] [Reference Citation Analysis]
323 Zhou YM, Yang RQ, Tao SC, Li Z, Zhang Q, Gao HF, Zhang ZW, Du JY, Zhu PX, Ren LL, Zhang L, Wang D, Guo L, Wang YB, Guo Y, Zhang Y, Zhao CZ, Wang C, Jiang D, Liu YH, Yang HW, Rong L, Zhao YJ, An S, Li Z, Fan XD, Wang JW, Cheng Y, Liu O, Zheng Z, Zuo HC, Shan QZ, Ruan L, Lü ZX, Hung T, Cheng J. The design and application of DNA chips for early detection of SARS-CoV from clinical samples. J Clin Virol 2005;33:123-31. [PMID: 15911427 DOI: 10.1016/j.jcv.2004.10.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
324 Fan S, Yan S, Liu X, Liu P, Huang L, Wang S. Human Coronavirus Infections and Pregnancy. Matern Fetal Med 2021;3:53-65. [PMID: 34192279 DOI: 10.1097/FM9.0000000000000071] [Reference Citation Analysis]
325 Kindler E, Jónsdóttir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RA, Drosten C, Müller MA, Dijkman R, Thiel V. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 2013;4:e00611-12. [PMID: 23422412 DOI: 10.1128/mBio.00611-12] [Cited by in Crossref: 133] [Cited by in F6Publishing: 118] [Article Influence: 14.8] [Reference Citation Analysis]
326 Chen Y, Chan VS, Zheng B, Chan KY, Xu X, To LY, Huang FP, Khoo US, Lin CL. A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med 2007;204:2529-36. [PMID: 17923501 DOI: 10.1084/jem.20070462] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
327 Wu D, Tu C, Xin C, Xuan H, Meng Q, Liu Y, Yu Y, Guan Y, Jiang Y, Yin X, Crameri G, Wang M, Li C, Liu S, Liao M, Feng L, Xiang H, Sun J, Chen J, Sun Y, Gu S, Liu N, Fu D, Eaton BT, Wang LF, Kong X. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol 2005;79:2620-5. [PMID: 15681462 DOI: 10.1128/JVI.79.4.2620-2625.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
328 Liao QJ, Ye LB, Timani KA, Zeng YC, She YL, Ye L, Wu ZH. Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus. Acta Biochim Biophys Sin (Shanghai) 2005;37:607-12. [PMID: 16143815 DOI: 10.1111/j.1745-7270.2005.00082.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
329 Tan YJ, Fielding BC, Goh PY, Shen S, Tan TH, Lim SG, Hong W. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol 2004;78:14043-7. [PMID: 15564512 DOI: 10.1128/JVI.78.24.14043-14047.2004] [Cited by in Crossref: 148] [Article Influence: 8.2] [Reference Citation Analysis]
330 Tiwari M, Mishra D. Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design. J Clin Virol 2020;128:104441. [PMID: 32425659 DOI: 10.1016/j.jcv.2020.104441] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
331 Chen W, Yan M, Yang L, Ding B, He B, Wang Y, Liu X, Liu C, Zhu H, You B, Huang S, Zhang J, Mu F, Xiang Z, Feng X, Wen J, Fang J, Yu J, Yang H, Wang J. SARS-associated coronavirus transmitted from human to pig. Emerg Infect Dis 2005;11:446-8. [PMID: 15757562 DOI: 10.3201/eid1103.040824] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
332 Zhao J, Zhou H, Huang W, Zhou J, Qiu M, Deng Z, Chen L, Weng Y, Cai L, Gu Y, Zheng Q, Chen Q, Hou X, Wang L, Shen L, Yang Z. Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy. J Thorac Dis 2020;12:4368-73. [PMID: 32944349 DOI: 10.21037/jtd-20-1368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
333 Chen LR, Wang YC, Lin YW, Chou SY, Chen SF, Liu LT, Wu YT, Kuo CJ, Chen TS, Juang SH. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorg Med Chem Lett 2005;15:3058-62. [PMID: 15896959 DOI: 10.1016/j.bmcl.2005.04.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 5.8] [Reference Citation Analysis]
334 Hui DS. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clin Chest Med 2017;38:71-86. [PMID: 28159163 DOI: 10.1016/j.ccm.2016.11.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 12.5] [Reference Citation Analysis]
335 Ieven M. Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections. J Clin Virol 2007;40:259-76. [PMID: 17977063 DOI: 10.1016/j.jcv.2007.08.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
336 Shi Y, Wan Z, Li L, Li P, Li C, Ma Q, Cao C. Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients. J Clin Virol 2004;31:66-8. [PMID: 15288616 DOI: 10.1016/j.jcv.2004.05.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
337 Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004;363:2122-7. [PMID: 15220033 DOI: 10.1016/S0140-6736(04)16501-X] [Cited by in Crossref: 183] [Cited by in F6Publishing: 141] [Article Influence: 10.2] [Reference Citation Analysis]
338 Miura TA, Holmes KV. Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells. J Leukoc Biol 2009;86:1145-51. [PMID: 19638499 DOI: 10.1189/jlb.0209078] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
339 Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, Jung SY, Ho MS, Liang KY, Chen HY, Chan YJ, Chu DC. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006;44:359-365. [PMID: 16455884 DOI: 10.1128/jcm.44.2.359-365.2006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
340 Haas W, Krause G, Marcus U, Stark K, Ammon A, Burger R. ["Emerging infectious diseases". Dengue-fever, West-Nile-fever, SARS, avian influenza, HIV]. Internist (Berl) 2004;45:684-92. [PMID: 15107983 DOI: 10.1007/s00108-004-1199-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
341 Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem 2004;50:67-72. [PMID: 14709637 DOI: 10.1373/clinchem.2003.023663] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
342 Santos FRDS, de Azevedo MSP, Bielavsky M, da Costa HHM, Ribeiro DG, Nascimento GGD, Marcondes GMP, de Castro BP, de Lima Neto DF, Prudencio CR. Mutational profile confers increased stability of SARS-CoV-2 spike protein in Brazilian isolates. J Biomol Struct Dyn 2021;:1-6. [PMID: 34633892 DOI: 10.1080/07391102.2021.1982775] [Reference Citation Analysis]
343 Dai J, Wang H, Liao Y, Tan L, Sun Y, Song C, Liu W, Qiu X, Ding C. Coronavirus Infection and Cholesterol Metabolism. Front Immunol 2022;13:791267. [DOI: 10.3389/fimmu.2022.791267] [Reference Citation Analysis]
344 Okada M, Takemoto Y, Okuno Y, Hashimoto S, Yoshida S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Matsumoto M, Kase T, Demello DE, Peiris JS, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine 2005;23:2269-72. [PMID: 15755609 DOI: 10.1016/j.vaccine.2005.01.036] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
345 Kohl C, Kurth A. European bats as carriers of viruses with zoonotic potential. Viruses 2014;6:3110-28. [PMID: 25123684 DOI: 10.3390/v6083110] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
346 Moal V, Zandotti C, Colson P. Emerging viral diseases in kidney transplant recipients. Rev Med Virol 2013;23:50-69. [PMID: 23132728 DOI: 10.1002/rmv.1732] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
347 Zhou Y, Chen L. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis. Int J Environ Res Public Health 2020;17:E3082. [PMID: 32354181 DOI: 10.3390/ijerph17093082] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
348 Cheng WC, Huang JC, Liou CY. Segmentation of DNA using simple recurrent neural network. Knowl Based Syst 2012;26:271-80. [PMID: 32288315 DOI: 10.1016/j.knosys.2011.09.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
349 Sampathkumar P, Temesgen Z, Smith TF, Thompson RL. SARS: epidemiology, clinical presentation, management, and infection control measures. Mayo Clin Proc 2003;78:882-90. [PMID: 12839084 DOI: 10.4065/78.7.882] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
350 Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect 2004;10:1062-6. [PMID: 15606632 DOI: 10.1111/j.1469-0691.2004.01009.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 143] [Article Influence: 9.4] [Reference Citation Analysis]
351 Guan M, Chen HY, Tan PH, Shen S, Goh PY, Tan YJ, Pang PH, Lu Y, Fong PY, Chin D. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clin Diagn Lab Immunol 2004;11:1148-53. [PMID: 15539520 DOI: 10.1128/CDLI.11.6.1148-1153.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
352 McBride R, Fielding BC. The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis. Viruses 2012;4:2902-23. [PMID: 23202509 DOI: 10.3390/v4112902] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 7.4] [Reference Citation Analysis]
353 Hu X, Deng Y, Wang J, Li H, Li M, Lu Z. Short term outcome and risk factors for mortality in adults with critical severe acute respiratory syndrome (SARS). J Huazhong Univ Sci Technolog Med Sci. 2004;24:514-517. [PMID: 15641708 DOI: 10.1007/bf02831124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
354 Maunder R. The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned. Philos Trans R Soc Lond B Biol Sci 2004;359:1117-25. [PMID: 15306398 DOI: 10.1098/rstb.2004.1483] [Cited by in Crossref: 164] [Cited by in F6Publishing: 149] [Article Influence: 9.1] [Reference Citation Analysis]
355 Regla-Nava JA, Nieto-Torres JL, Jimenez-Guardeño JM, Fernandez-Delgado R, Fett C, Castaño-Rodríguez C, Perlman S, Enjuanes L, DeDiego ML. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol 2015;89:3870-87. [PMID: 25609816 DOI: 10.1128/JVI.03566-14] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
356 Roh C, Jo SK. Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip. J Chem Technol Biotechnol 2011;86:1475-9. [PMID: 32336860 DOI: 10.1002/jctb.2721] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
357 Lu W, Zhao Z, Huang Y, Wang B. Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic. International Journal of Biological Macromolecules 2022;200:487-97. [DOI: 10.1016/j.ijbiomac.2022.01.108] [Reference Citation Analysis]
358 Sullivan BN, Fischer T. Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis. Front Aging Neurosci 2021;13:653694. [PMID: 34408638 DOI: 10.3389/fnagi.2021.653694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
359 Cui J, Han N, Streicker D, Li G, Tang X, Shi Z, Hu Z, Zhao G, Fontanet A, Guan Y, Wang L, Jones G, Field HE, Daszak P, Zhang S. Evolutionary relationships between bat coronaviruses and their hosts. Emerg Infect Dis 2007;13:1526-32. [PMID: 18258002 DOI: 10.3201/eid1310.070448] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
360 Franchini M, Liumbruno GM. Convalescent Plasma for the Treatment of Severe COVID-19. Biologics 2021;15:31-8. [PMID: 33574654 DOI: 10.2147/BTT.S272063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
361 Timani KA, Liao Q, Ye L, Zeng Y, Liu J, Zheng Y, Ye L, Yang X, Lingbao K, Gao J, Zhu Y. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res 2005;114:23-34. [PMID: 15992957 DOI: 10.1016/j.virusres.2005.05.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
362 El-Anwar MW, Eesa M, Mansour W, Zake LG, Hendawy E. Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients. Int Arch Otorhinolaryngol 2021;25:e343-8. [PMID: 34377166 DOI: 10.1055/s-0041-1730456] [Reference Citation Analysis]
363 Rebendenne A, Valadão ALC, Tauziet M, Maarifi G, Bonaventure B, McKellar J, Planès R, Nisole S, Arnaud-Arnould M, Moncorgé O, Goujon C. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol 2021:JVI. [PMID: 33514628 DOI: 10.1128/JVI.02415-20] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 29.0] [Reference Citation Analysis]
364 Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies. Front Immunol 2020;11:2130. [PMID: 33013898 DOI: 10.3389/fimmu.2020.02130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
365 Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution. Trends Microbiol 2014;22:573-9. [PMID: 25178651 DOI: 10.1016/j.tim.2014.08.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
366 Moriyama Y, Hamada H, Okada M, Tsuchiya N, Maru H, Shirato Y, Maeda Y, Hirose Y, Yoshida M, Omura Y, Honda T, Muto A, Hayashi K, Terai M. Distinctive clinical features of human bocavirus in children younger than 2 years. Eur J Pediatr 2010;169:1087-92. [PMID: 20383526 DOI: 10.1007/s00431-010-1183-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
367 Guihot A, Bricaire F, Li T, Bossi P. [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia]. Presse Med 2004;33:344-51. [PMID: 15041887 DOI: 10.1016/s0755-4982(04)98581-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
368 Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005;67:18-23. [PMID: 15885816 DOI: 10.1016/j.antiviral.2005.02.007] [Cited by in Crossref: 259] [Cited by in F6Publishing: 228] [Article Influence: 15.2] [Reference Citation Analysis]
369 Joshi A, Joshi BC, Mannan MA, Kaushik V. Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach. Inform Med Unlocked 2020;19:100338. [PMID: 32352026 DOI: 10.1016/j.imu.2020.100338] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 16.5] [Reference Citation Analysis]
370 Ziebuhr J. SARS--unprecedented global response to a newly emerging disease. Int J Med Microbiol 2003;293:229-31. [PMID: 14503787 DOI: 10.1078/1438-4221-00270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
371 Kulkarni R, Chen WC, Lee Y, Kao CF, Hu SL, Ma HH, Jan JT, Liao CC, Liang JJ, Ko HY, Sun CP, Lin YS, Wang YC, Wei SC, Lin YL, Ma C, Chao YC, Chou YC, Chang W. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS One 2021;16:e0257191. [PMID: 34499677 DOI: 10.1371/journal.pone.0257191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Zhai J, Briese T, Dai E, Wang X, pang X, Du Z, Liu H, Wang J, Wang H, Guo Z, Chen Z, Jiang L, Zhou D, Han Y, Jabado O, Palacios G, Lipkin WI, Tang R. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis 2004;10:300-3. [PMID: 15030701 DOI: 10.3201/eid1002.030799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
373 Yamashita M, Yamate M, Li GM, Ikuta K. Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus. Biochem Biophys Res Commun 2005;334:79-85. [PMID: 15992768 DOI: 10.1016/j.bbrc.2005.06.061] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
374 Chen YC, Huang LM, Chan CC, Su CP, Chang SC, Chang YY, Chen ML, Hung CC, Chen WJ, Lin FY, Lee YT; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782-8. [PMID: 15200809 DOI: 10.3201/eid1005.030579] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
375 Chow PK, Ooi EE, Tan HK, Ong KW, Sil BK, Teo M, Ng T, Soo KC. Healthcare worker seroconversion in SARS outbreak. Emerg Infect Dis 2004;10:249-50. [PMID: 15030691 DOI: 10.3201/eid1002.030397] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
376 Zhang X, Alekseev K, Jung K, Vlasova A, Hadya N, Saif LJ. Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome. J Virol. 2008;82:4420-4428. [PMID: 18287230 DOI: 10.1128/jvi.02190-07] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
377 Chan PK, To KF, Lo AW, Cheung JL, Chu I, Au FW, Tong JH, Tam JS, Sung JJ, Ng HK. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol 2004;74:1-7. [PMID: 15258961 DOI: 10.1002/jmv.20138] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.4] [Reference Citation Analysis]
378 Parkhe P, Verma S. Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses. Front Vet Sci 2021;8:719834. [PMID: 34738021 DOI: 10.3389/fvets.2021.719834] [Reference Citation Analysis]
379 Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264-268. [PMID: 15351731 DOI: 10.1016/j.bbrc.2004.08.085] [Cited by in Crossref: 376] [Cited by in F6Publishing: 346] [Article Influence: 20.9] [Reference Citation Analysis]
380 Huang SW, Wang SF. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity. Int J Mol Sci 2021;22:3060. [PMID: 33802729 DOI: 10.3390/ijms22063060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
381 Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen. Nat Commun 2022;13:2442. [PMID: 35508460 DOI: 10.1038/s41467-022-30134-9] [Reference Citation Analysis]
382 Stobart CC, Lee AS, Lu X, Denison MR. Temperature-sensitive mutants and revertants in the coronavirus nonstructural protein 5 protease (3CLpro) define residues involved in long-distance communication and regulation of protease activity. J Virol 2012;86:4801-10. [PMID: 22345451 DOI: 10.1128/JVI.06754-11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
383 Ng JH, Zaidan M, Jhaveri KD, Izzedine H. Acute tubulointerstitial nephritis and COVID-19. Clin Kidney J 2021;14:2151-7. [PMID: 34603692 DOI: 10.1093/ckj/sfab107] [Reference Citation Analysis]
384 Wang XW, Li JS, Guo TK, Zhen B, Kong QX, Yi B, Li Z, Song N, Jin M, Wu XM, Xiao WJ, Zhu XM, Gu CQ, Yin J, Wei W, Yao W, Liu C, Li JF, Ou GR, Wang MN, Fang TY, Wang GJ, Qiu YH, Wu HH, Chao FH, Li JW. Excretion and detection of SARS coronavirus and its nucleic acid from digestive system. World J Gastroenterol 2005; 11(28): 4390-4395 [PMID: 16038039 DOI: 10.3748/wjg.v11.i28.4390] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
385 Hong N, Du X, Nie Z, Li S. Diffusion-weighted MR study of femoral head avascular necrosis in severe acute respiratory syndrome patients. J Magn Reson Imaging 2005;22:661-4. [PMID: 16193472 DOI: 10.1002/jmri.20430] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
386 Wei P, Cai Z, Hua J, Yu W, Chen J, Kang K, Qiu C, Ye L, Hu J, Ji K. Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9. Biomed Res Int 2016;2016:5717108. [PMID: 27525272 DOI: 10.1155/2016/5717108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
387 Chen J, Miao L, Li JM, Li YY, Zhu QY, Zhou CL, Fang HQ, Chen HP. Receptor-binding domain of SARS-Cov spike protein: Soluble expression in E.coli, purification and functional characterization. World J Gastroenterol 2005; 11(39): 6159-6164 [PMID: 16273643 DOI: 10.3748/wjg.v11.i39.6159] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
388 Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah EE, Badu EK, Anti P, Agbenyega O, Meyer B, Oppong S, Sarkodie YA, Kalko EK, Lina PH, Godlevska EV, Reusken C, Seebens A, Gloza-Rausch F, Vallo P, Tschapka M, Drosten C, Drexler JF. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis 2013;19:456-9. [PMID: 23622767 DOI: 10.3201/eid1903.121503] [Cited by in Crossref: 230] [Cited by in F6Publishing: 226] [Article Influence: 25.6] [Reference Citation Analysis]
389 Lateef F. SARS changes the ED paradigm. Am J Emerg Med 2004;22:483-7. [PMID: 15520944 DOI: 10.1016/j.ajem.2004.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
390 Smith G, Smith I, Harrower B, Warrilow D, Bletchly C. A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents. J Virol Methods 2006;135:229-34. [PMID: 16677717 DOI: 10.1016/j.jviromet.2006.03.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
391 Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J Allergy Clin Immunol 2020;146:285-99. [PMID: 32624257 DOI: 10.1016/j.jaci.2020.05.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
392 Mykytyn AZ, Breugem TI, Riesebosch S, Schipper D, van den Doel PB, Rottier RJ, Lamers MM, Haagmans BL. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. Elife 2021;10:e64508. [PMID: 33393462 DOI: 10.7554/eLife.64508] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 28.0] [Reference Citation Analysis]
393 He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 2005;334:74-82. [PMID: 15749124 DOI: 10.1016/j.virol.2005.01.034] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
394 Ragan I, Hartson L, Pidcoke H, Bowen R, Goodrich R. Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light. PLoS One 2020;15:e0233947. [PMID: 32470046 DOI: 10.1371/journal.pone.0233947] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 20.0] [Reference Citation Analysis]
395 Liu MQ, Jiang RD, Guo J, Chen Y, Yang DS, Wang X, Lin HF, Li A, Li B, Hu B, Wang ZJ, Yang XL, Shi ZL. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice. J Virol 2022;:e0016922. [PMID: 35343762 DOI: 10.1128/jvi.00169-22] [Reference Citation Analysis]
396 El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx 2020;47:559-64. [PMID: 32586739 DOI: 10.1016/j.anl.2020.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
397 Goli M. Review of novel human β-coronavirus (2019-nCoV or SARS-CoV-2) from the food industry perspective-Appropriate approaches to food production technology. Food Sci Nutr 2020. [PMID: 33042532 DOI: 10.1002/fsn3.1892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
398 Abdul-Rasool S, Fielding BC. Understanding Human Coronavirus HCoV-NL63. Open Virol J 2010;4:76-84. [PMID: 20700397 DOI: 10.2174/1874357901004010076] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
399 Horejsh D, Martini F, Poccia F, Ippolito G, Di Caro A, Capobianchi MR. A molecular beacon, bead-based assay for the detection of nucleic acids by flow cytometry. Nucleic Acids Res 2005;33:e13. [PMID: 15659574 DOI: 10.1093/nar/gni015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
400 Stip E, Rizvi TA, Mustafa F, Javaid S, Aburuz S, Ahmed NN, Abdel Aziz K, Arnone D, Subbarayan A, Al Mugaddam F, Khan G. The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19. Front Pharmacol 2020;11:577678. [PMID: 33390948 DOI: 10.3389/fphar.2020.577678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
401 Marom T, Pitaro J, Shah UK, Torretta S, Marchisio P, Kumar AT, Barth PC, Tamir SO. Otitis Media Practice During the COVID-19 Pandemic. Front Cell Infect Microbiol 2021;11:749911. [PMID: 35071032 DOI: 10.3389/fcimb.2021.749911] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Ebihara T, Masuda A, Takahashi D, Hino M, Mon H, Kakino K, Fujii T, Fujita R, Ueda T, Lee JM, Kusakabe T. Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System. Mol Biotechnol 2021. [PMID: 34304364 DOI: 10.1007/s12033-021-00373-0] [Reference Citation Analysis]
403 Saikatendu KS, Joseph JS, Subramanian V, Clayton T, Griffith M, Moy K, Velasquez J, Neuman BW, Buchmeier MJ, Stevens RC, Kuhn P. Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3. Structure 2005;13:1665-75. [PMID: 16271890 DOI: 10.1016/j.str.2005.07.022] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 10.3] [Reference Citation Analysis]
404 Zhang CH, Lu JH, Wang YF, Zheng HY, Xiong S, Zhang MY, Liu XJ, Li JX, Wan ZY, Yan XG, Qi SY, Cui Z, Zhang B. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. Vaccine 2005;23:3196-201. [PMID: 15837220 DOI: 10.1016/j.vaccine.2004.11.073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
405 Olusola-Makinde OO, Makinde OS. COVID-19 incidence and mortality in Nigeria: gender based analysis. PeerJ 2021;9:e10613. [PMID: 33614262 DOI: 10.7717/peerj.10613] [Reference Citation Analysis]
406 El Hassab MA, Shoun AA, Al-Rashood ST, Al-Warhi T, Eldehna WM. Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations. Front Chem 2020;8:584894. [PMID: 33195080 DOI: 10.3389/fchem.2020.584894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
407 Peeling RW. Diagnostics in a digital age: an opportunity to strengthen health systems and improve health outcomes. Int Health 2015;7:384-9. [PMID: 26553825 DOI: 10.1093/inthealth/ihv062] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
408 McBryde ES, Gibson G, Pettitt AN, Zhang Y, Zhao B, McElwain DL. Bayesian modelling of an epidemic of severe acute respiratory syndrome. Bull Math Biol 2006;68:889-917. [PMID: 16802088 DOI: 10.1007/s11538-005-9005-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
409 Richard M, Knauf S, Lawrence P, Mather AE, Munster VJ, Müller MA, Smith D, Kuiken T. Factors determining human-to-human transmissibility of zoonotic pathogens via contact. Curr Opin Virol 2017;22:7-12. [PMID: 27907884 DOI: 10.1016/j.coviro.2016.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
410 Hui DS, Sung JJ. Severe acute respiratory syndrome. Chest 2003;124:12-5. [PMID: 12853495 DOI: 10.1378/chest.124.1.12] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
411 Shao YM, Yang WB, Peng HP, Hsu MF, Tsai KC, Kuo TH, Wang AH, Liang PH, Lin CH, Yang AS, Wong CH. Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. Chembiochem 2007;8:1654-7. [PMID: 17722121 DOI: 10.1002/cbic.200700254] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
412 Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU, Mohamed MA. Isatin derivatives as broad-spectrum antiviral agents: the current landscape. Med Chem Res 2022;:1-30. [PMID: 35039740 DOI: 10.1007/s00044-021-02832-4] [Reference Citation Analysis]
413 Diniz LRL, Elshabrawy HA, Souza MTS, Duarte ABS, Datta S, de Sousa DP. Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury. Molecules 2021;26:5951. [PMID: 34641495 DOI: 10.3390/molecules26195951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Weidmann M, Zanotto PM, Weber F, Spiegel M, Brodt HR, Hufert FT. High-efficiency detection of severe acute respiratory syndrome virus genetic material. J Clin Microbiol 2004;42:2771-3. [PMID: 15184466 DOI: 10.1128/JCM.42.6.2771-2773.2004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
415 Muthusami R, Saritha K. Statistical analysis and visualization of the potential cases of pandemic coronavirus. Virusdisease 2020;31:204-8. [PMID: 32656312 DOI: 10.1007/s13337-020-00610-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
416 Leli C, Di Matteo L, Gotta F, Cornaglia E, Vay D, Megna I, Pensato RE, Boverio R, Rocchetti A. Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department. Int J Infect Dis 2021;110:135-40. [PMID: 34302961 DOI: 10.1016/j.ijid.2021.07.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Frieman M, Basu D, Matthews K, Taylor J, Jones G, Pickles R, Baric R, Engel DA. Yeast based small molecule screen for inhibitors of SARS-CoV. PLoS One 2011;6:e28479. [PMID: 22164298 DOI: 10.1371/journal.pone.0028479] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
418 Hognon C, Marazzi M, García-Iriepa C. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease. Int J Mol Sci 2022;23:5855. [PMID: 35628665 DOI: 10.3390/ijms23105855] [Reference Citation Analysis]
419 Schneider M, Ackermann K, Stuart M, Wex C, Protzer U, Schätzl HM, Gilch S. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol 2012;86:10112-22. [PMID: 22787216 DOI: 10.1128/JVI.01001-12] [Cited by in Crossref: 82] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
420 Lu W, Wu XD, Shi MD, Yang RF, He YY, Bian C, Shi TL, Yang S, Zhu XL, Jiang WH, Li YX, Yan LC, Ji YY, Lin Y, Lin GM, Tian L, Wang J, Wang HX, Xie YH, Pei G, Wu JR, Sun B. Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential. FEBS Lett 2005;579:2130-6. [PMID: 15811330 DOI: 10.1016/j.febslet.2005.02.070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
421 de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RW, Posthuma CC, van der Meer Y, Bárcena M, Haagmans BL. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J Gen Virol. 2013;94:1749-1760. [PMID: 23620378 DOI: 10.1099/vir.0.052910-0] [Cited by in Crossref: 228] [Cited by in F6Publishing: 224] [Article Influence: 25.3] [Reference Citation Analysis]
422 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
423 van Boheemen S, Bestebroer TM, Verhagen JH, Osterhaus AD, Pas SD, Herfst S, Fouchier RA. A family-wide RT-PCR assay for detection of paramyxoviruses and application to a large-scale surveillance study. PLoS One 2012;7:e34961. [PMID: 22496880 DOI: 10.1371/journal.pone.0034961] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
424 Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog 2014;10:e1004166. [PMID: 24874215 DOI: 10.1371/journal.ppat.1004166] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 12.4] [Reference Citation Analysis]
425 Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003;58:686-9. [PMID: 12885985 DOI: 10.1136/thorax.58.8.686] [Cited by in Crossref: 216] [Cited by in F6Publishing: 203] [Article Influence: 11.4] [Reference Citation Analysis]
426 Cavallazzi R, Ramirez JA. Influenza and Viral Pneumonia. Clin Chest Med 2018;39:703-21. [PMID: 30390743 DOI: 10.1016/j.ccm.2018.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
427 Matthews K, Schäfer A, Pham A, Frieman M. The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity. Virol J 2014;11:209. [PMID: 25481026 DOI: 10.1186/s12985-014-0209-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
428 Yang N, Ma P, Lang J, Zhang Y, Deng J, Ju X, Zhang G, Jiang C. Phosphatidylinositol 4-kinase IIIβ is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. J Biol Chem. 2012;287:8457-8467. [PMID: 22253445 DOI: 10.1074/jbc.m111.312561] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
429 Nakagawa K, Narayanan K, Wada M, Makino S. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication. J Virol 2018;92:e00902-18. [PMID: 30068649 DOI: 10.1128/JVI.00902-18] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 10.5] [Reference Citation Analysis]
430 Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 2013;4:e00524-13. [PMID: 23943763 DOI: 10.1128/mBio.00524-13] [Cited by in Crossref: 201] [Cited by in F6Publishing: 161] [Article Influence: 22.3] [Reference Citation Analysis]
431 Wang S, Sakhatskyy P, Chou TH, Lu S. Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). J Immunol Methods 2005;301:21-30. [PMID: 15894326 DOI: 10.1016/j.jim.2005.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
432 Li L, Wang X, Hua Y, Liu P, Zhou J, Chen J, An F, Hou F, Huang W, Chen J. Epidemiological Study of Betacoronaviruses in Captive Malayan Pangolins. Front Microbiol 2021;12:657439. [PMID: 33763052 DOI: 10.3389/fmicb.2021.657439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
433 Yang L, Peng H, Zhu Z, Li G, Huang Z, Zhao Z, Koup RA, Bailer RT, Wu C. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen. J Gen Virol 2007;88:2740-8. [PMID: 17872527 DOI: 10.1099/vir.0.82839-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
434 Nogales A, Galán C, Márquez-Jurado S, García-Gallo M, Kremer L, Enjuanes L, Almazán F. Immunogenic characterization and epitope mapping of transmissible gastroenteritis virus RNA dependent RNA polymerase. J Virol Methods 2011;175:7-13. [PMID: 21513742 DOI: 10.1016/j.jviromet.2011.04.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
435 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
436 Kuiken T, Fouchier R, Rimmelzwaan G, Osterhaus A. Emerging viral infections in a rapidly changing world. Curr Opin Biotechnol 2003;14:641-6. [PMID: 14662395 DOI: 10.1016/j.copbio.2003.10.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
437 Liu Y, Liang C, Xin L, Ren X, Tian L, Ju X, Li H, Wang Y, Zhao Q, Liu H, Cao W, Xie X, Zhang D, Wang Y, Jian Y. The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. Eur J Med Chem 2020;206:112711. [PMID: 32810751 DOI: 10.1016/j.ejmech.2020.112711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
438 De Clercq E. Potential antivirals and antiviral strategies against SARS coronavirus infections. Expert Rev Anti Infect Ther 2006;4:291-302. [PMID: 16597209 DOI: 10.1586/14787210.4.2.291] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
439 Lv Y, Ruan Z, Wang L, Ni B, Wu Y. Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. BMC Immunol 2009;10:61. [PMID: 19958537 DOI: 10.1186/1471-2172-10-61] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
440 Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong HN. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88:861-3. [PMID: 15205225 DOI: 10.1136/bjo.2003.035931] [Cited by in Crossref: 162] [Cited by in F6Publishing: 135] [Article Influence: 9.0] [Reference Citation Analysis]
441 Tan J, Mu L, Huang J, Yu S, Chen B, Yin J. An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation. J Epidemiol Community Health 2005;59:186-92. [PMID: 15709076 DOI: 10.1136/jech.2004.020180] [Cited by in Crossref: 157] [Cited by in F6Publishing: 122] [Article Influence: 9.2] [Reference Citation Analysis]
442 Inoue M, Barkham T, Keong LK, Gee LS, Wanjin H. Performance of single-step gel-based reverse transcription-PCR (RT-PCR) assays equivalent to that of real-time RT-PCR assays for detection of the severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2005;43:4262-5. [PMID: 16081995 DOI: 10.1128/JCM.43.8.4262-4265.2005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
443 Hetrick B, Yu D, Olanrewaju AA, Chilin LD, He S, Dabbagh D, Alluhaibi G, Ma YC, Hofmann LA, Hakami RM, Wu Y. A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro. Cell Biosci 2021;11:100. [PMID: 34051873 DOI: 10.1186/s13578-021-00609-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YD, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, Pan HY, He WZ, Manuguerra JC, Fontanet A, Danchin A, Niccolai N, Li YX, Wu CI, Zhao GP. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA. 2005;102:2430-2435. [PMID: 15695582 DOI: 10.1073/pnas.0409608102] [Cited by in Crossref: 432] [Cited by in F6Publishing: 386] [Article Influence: 25.4] [Reference Citation Analysis]
445 Navas-Martín SR, Weiss S. Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol 2004;10:75-85. [PMID: 15204926 DOI: 10.1080/13550280490280292] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
446 Zhao P, Qin ZL, Ke JS, Lu Y, Liu M, Pan W, Zhao LJ, Cao J, Qi ZT. Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. FEBS Lett 2005;579:2404-10. [PMID: 15848179 DOI: 10.1016/j.febslet.2005.02.080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
447 DeDiego ML, Alvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol 2007;81:1701-13. [PMID: 17108030 DOI: 10.1128/JVI.01467-06] [Cited by in Crossref: 221] [Cited by in F6Publishing: 172] [Article Influence: 13.8] [Reference Citation Analysis]
448 He R, Leeson A, Andonov A, Li Y, Bastien N, Cao J, Osiowy C, Dobie F, Cutts T, Ballantine M, Li X. Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem Biophys Res Commun 2003;311:870-6. [PMID: 14623261 DOI: 10.1016/j.bbrc.2003.10.075] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 4.8] [Reference Citation Analysis]
449 Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181-192. [PMID: 30531947 DOI: 10.1038/s41579-018-0118-9] [Cited by in Crossref: 2061] [Cited by in F6Publishing: 1744] [Article Influence: 1030.5] [Reference Citation Analysis]
450 Oh HL, Chia A, Chang CX, Leong HN, Ling KL, Grotenbreg GM, Gehring AJ, Tan YJ, Bertoletti A. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope. J Virol 2011;85:10464-71. [PMID: 21813600 DOI: 10.1128/JVI.05039-11] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
451 Shih MC, Peck K, Chan WL, Chu YP, Chen JC, Tsai CH, Chang JG. SARS-CoV infection was from at least two origins in the Taiwan area. Intervirology 2005;48:124-32. [PMID: 15812185 DOI: 10.1159/000081739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
452 García-Menaya JM, Cordobés-Durán C, Rangel-Mayoral JF, García-Martín E, Agúndez JAG. Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital. Front Pharmacol 2020;11:570721. [PMID: 33041811 DOI: 10.3389/fphar.2020.570721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
453 Pyrc K, Jebbink MF, Berkhout B, van der Hoek L. Genome structure and transcriptional regulation of human coronavirus NL63. Virol J 2004;1:7. [PMID: 15548333 DOI: 10.1186/1743-422X-1-7] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
454 Chan HL, Tsui SK, Sung JJ. Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol Med 2003;9:323-5. [PMID: 12928031 DOI: 10.1016/s1471-4914(03)00135-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
455 Yang ZY, Werner HC, Kong WP, Leung K, Traggiai E, Lanzavecchia A, Nabel GJ. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 2005;102:797-801. [PMID: 15642942 DOI: 10.1073/pnas.0409065102] [Cited by in Crossref: 179] [Cited by in F6Publishing: 169] [Article Influence: 10.5] [Reference Citation Analysis]
456 Konno S, Thanigaimalai P, Yamamoto T, Nakada K, Kakiuchi R, Takayama K, Yamazaki Y, Yakushiji F, Akaji K, Kiso Y, Kawasaki Y, Chen SE, Freire E, Hayashi Y. Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. Bioorg Med Chem 2013;21:412-24. [PMID: 23245752 DOI: 10.1016/j.bmc.2012.11.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
457 Kolawole O, Oguntoye M, Dam T, Chunara R. Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria. BMC Res Notes 2017;10:712. [PMID: 29212531 DOI: 10.1186/s13104-017-3063-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
458 Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Wang X, Zhou G, Zhang T, Li B, Wang Y, Chen Z, Wang X. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 2020;18:206. [PMID: 32434518 DOI: 10.1186/s12967-020-02374-0] [Cited by in Crossref: 240] [Cited by in F6Publishing: 224] [Article Influence: 120.0] [Reference Citation Analysis]
459 Kojin H, Inoue O, Kinouchi H. A Study of the Patient Acceptance Capacity of the Yamanashi Prefecture Medical System amid the Coronavirus Disease 2019 Pandemic. JMA J 2021;4:24-31. [PMID: 33575500 DOI: 10.31662/jmaj.2020-0034] [Reference Citation Analysis]
460 Poon LLM, Chan KH, Nicholls JM, Zheng BJ, Yuen KY, Guan Y, Peiris JSM. Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Int Congr Ser 2004;1263:805-8. [PMID: 32288144 DOI: 10.1016/j.ics.2004.02.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
461 Farquharson C, Baguley K. Responding to the Severe Acute Respiratory Syndrome (SARS) Outbreak: Lessons Learned in a Toronto Emergency Department. J Emerg Nurs 2020;46:742-7. [PMID: 33162020 DOI: 10.1016/j.jen.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
462 Gebretsadik D, Gebremichael S, Belete MA. Knowledge, Attitude and Practice Toward COVID-19 Pandemic Among Population Visiting Dessie Health Center for COVID-19 Screening, Northeast Ethiopia. Infect Drug Resist 2021;14:905-15. [PMID: 33716509 DOI: 10.2147/IDR.S297047] [Reference Citation Analysis]
463 Grubaugh ND, Ladner JT, Lemey P, Pybus OG, Rambaut A, Holmes EC, Andersen KG. Tracking virus outbreaks in the twenty-first century. Nat Microbiol 2019;4:10-9. [PMID: 30546099 DOI: 10.1038/s41564-018-0296-2] [Cited by in Crossref: 156] [Cited by in F6Publishing: 123] [Article Influence: 39.0] [Reference Citation Analysis]
464 Petrie JG, Bazzi LA, McDermott AB, Follmann D, Esposito D, Hatcher C, Mateja A, Narpala SR, O'Connell SE, Martin ET, Monto AS. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. J Infect Dis 2021;224:49-59. [PMID: 33755731 DOI: 10.1093/infdis/jiab161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
465 Hsu MF, Kuo CJ, Chang KT, Chang HC, Chou CC, Ko TP, Shr HL, Chang GG, Wang AH, Liang PH. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem 2005;280:31257-66. [PMID: 15788388 DOI: 10.1074/jbc.M502577200] [Cited by in Crossref: 131] [Cited by in F6Publishing: 94] [Article Influence: 7.7] [Reference Citation Analysis]
466 Manyati TK, Mutsau M. Exploring the effectiveness of telehealth interventions for diagnosis, contact tracing and care of Corona Virus Disease of 2019 (COVID19) patients in sub Saharan Africa: a rapid review. Health Technol (Berl) 2021;:1-8. [PMID: 33585154 DOI: 10.1007/s12553-020-00485-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
467 Pouladi N, Abdolahi S. Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis. Mol Genet Genomic Med 2021;9:e1672. [PMID: 33818000 DOI: 10.1002/mgg3.1672] [Reference Citation Analysis]
468 Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AMG, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 2020;98:115094. [PMID: 32623267 DOI: 10.1016/j.diagmicrobio.2020.115094] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 49.5] [Reference Citation Analysis]
469 Rivero-Calle I, Gómez-Rial J, Bont L, Gessner BD, Kohn M, Dagan R, Payne DC, Bruni L, Pollard AJ, García-Sastre A, Faustman DL, Osterhaus A, Butler R, Giménez Sánchez F, Álvarez F, Kaforou M, Bello X, Martinón-Torres F. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Hum Vaccin Immunother 2021;17:759-72. [PMID: 32755474 DOI: 10.1080/21645515.2020.1788301] [Reference Citation Analysis]
470 Araujo DB, Machado RRG, Amgarten DE, Malta FM, de Araujo GG, Monteiro CO, Candido ED, Soares CP, de Menezes FG, Pires ACC, Santana RAF, Viana AO, Dorlass E, Thomazelli L, Ferreira LCS, Botosso VF, Carvalho CRG, Oliveira DBL, Pinho JRR, Durigon EL. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Mem Inst Oswaldo Cruz 2020;115:e200342. [PMID: 33111751 DOI: 10.1590/0074-02760200342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
471 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
472 Liu W, Tang F, Fontanet A, Zhan L, Wang TB, Zhang PH, Luan YH, Cao CY, Zhao QM, Wu XM, Xin ZT, Zuo SQ, Baril L, Vabret A, Shao YM, Yang H, Cao WC. Molecular epidemiology of SARS-associated coronavirus, Beijing. Emerg Infect Dis 2005;11:1420-4. [PMID: 16229772 DOI: 10.3201/eid1109.040773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
473 Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, Müller TH, Seltsam A. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively. Transfusion 2018;58:2202-7. [PMID: 29732571 DOI: 10.1111/trf.14652] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 13.5] [Reference Citation Analysis]
474 El-Rashidy N, Abdelrazik S, Abuhmed T, Amer E, Ali F, Hu JW, El-Sappagh S. Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic. Diagnostics (Basel) 2021;11:1155. [PMID: 34202587 DOI: 10.3390/diagnostics11071155] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Ramírez JD, Muñoz M, Hernández C, Flórez C, Gomez S, Rico A, Pardo L, Barros EC, Paniz-Mondolfi AE. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection. Pathogens 2020;9:E580. [PMID: 32708840 DOI: 10.3390/pathogens9070580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
476 Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005;53:47-55. [PMID: 15994050 DOI: 10.1016/j.diagmicrobio.2005.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
477 Karijo E, Wamugi S, Lemanyishoe S, Njuki J, Boit F, Kibui V, Karanja S, Abuya T. Knowledge, attitudes, practices, and the effects of COVID-19 among the youth in Kenya. BMC Public Health 2021;21:1020. [PMID: 34053442 DOI: 10.1186/s12889-021-11067-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
478 Yount B, Roberts RS, Sims AC, Deming D, Frieman MB, Sparks J, Denison MR, Davis N, Baric RS. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J Virol 2005;79:14909-22. [PMID: 16282490 DOI: 10.1128/JVI.79.23.14909-14922.2005] [Cited by in Crossref: 185] [Cited by in F6Publishing: 155] [Article Influence: 11.6] [Reference Citation Analysis]
479 De Groot AS. How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine 2003;21:4095-104. [PMID: 14505885 DOI: 10.1016/s0264-410x(03)00489-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
480 Cho HJ, Koo JW, Roh SK, Kim YK, Suh JS, Moon JH, Sohn SK, Baek DW. COVID-19 transmission and blood transfusion: A case report. J Infect Public Health. 2020;13:1678-1679. [PMID: 32405329 DOI: 10.1016/j.jiph.2020.05.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
481 Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004;10:S88-97. [PMID: 15577937 DOI: 10.1038/nm1143] [Cited by in Crossref: 636] [Cited by in F6Publishing: 564] [Article Influence: 37.4] [Reference Citation Analysis]
482 Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2010;84:1289-1301. [PMID: 19906920 DOI: 10.1128/jvi.01281-09] [Cited by in Crossref: 241] [Cited by in F6Publishing: 177] [Article Influence: 18.5] [Reference Citation Analysis]
483 Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
484 Decrey L, Kazama S, Kohn T. Ammonia as an In Situ Sanitizer: Influence of Virus Genome Type on Inactivation. Appl Environ Microbiol 2016;82:4909-20. [PMID: 27260358 DOI: 10.1128/AEM.01106-16] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
485 Martínez-Salazar B, Holwerda M, Stüdle C, Piragyte I, Mercader N, Engelhardt B, Rieben R, Döring Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front Cell Dev Biol 2022;10:824851. [PMID: 35242762 DOI: 10.3389/fcell.2022.824851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
486 Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol 2015;235:185-95. [PMID: 25270030 DOI: 10.1002/path.4454] [Cited by in Crossref: 177] [Cited by in F6Publishing: 175] [Article Influence: 25.3] [Reference Citation Analysis]
487 Yap Y, Zhang X, Andonov A, He R. Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins. Comput Biol Chem 2005;29:212-9. [PMID: 15979041 DOI: 10.1016/j.compbiolchem.2005.04.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
488 Thura M, Sng JXE, Ang KH, Li J, Gupta A, Hong JM, Hong CW, Zeng Q. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs. Biosci Rep 2021;41:BSR20211491. [PMID: 34519332 DOI: 10.1042/BSR20211491] [Reference Citation Analysis]
489 Peng TY, Lee KR, Tarn WY. Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization. FEBS J 2008;275:4152-63. [PMID: 18631359 DOI: 10.1111/j.1742-4658.2008.06564.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
490 Moës E, Vijgen L, Keyaerts E, Zlateva K, Li S, Maes P, Pyrc K, Berkhout B, van der Hoek L, Van Ranst M. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 2005;5:6. [PMID: 15686594 DOI: 10.1186/1471-2334-5-6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 108] [Article Influence: 6.4] [Reference Citation Analysis]
491 Morty RE, Ziebuhr J. Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection. Am J Physiol Lung Cell Mol Physiol 2020;318:L1016-9. [PMID: 32266822 DOI: 10.1152/ajplung.00136.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
492 El-rashidy N, El-sappagh S, Islam SMR, El-bakry HM, Abdelrazek S. End-To-End Deep Learning Framework for Coronavirus (COVID-19) Detection and Monitoring. Electronics 2020;9:1439. [DOI: 10.3390/electronics9091439] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]
493 Chan PK, Chan MC. Tracing the SARS-coronavirus. J Thorac Dis 2013;5 Suppl 2:S118-21. [PMID: 23977431 DOI: 10.3978/j.issn.2072-1439.2013.06.19] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
494 Akaji K, Konno H. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease. Molecules 2020;25:E3920. [PMID: 32867349 DOI: 10.3390/molecules25173920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
495 Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases. Viruses 2014;6:2735-61. [PMID: 25036462 DOI: 10.3390/v6072735] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 9.0] [Reference Citation Analysis]
496 Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020;79:104212. [PMID: 32004758 DOI: 10.1016/j.meegid.2020.104212] [Cited by in Crossref: 302] [Cited by in F6Publishing: 258] [Article Influence: 151.0] [Reference Citation Analysis]
497 Yu CJ, Chen YC, Hsiao CH, Kuo TC, Chang SC, Lu CY, Wei WC, Lee CH, Huang LM, Chang MF, Ho HN, Lee FJ. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett 2004;565:111-6. [PMID: 15135062 DOI: 10.1016/j.febslet.2004.03.086] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
498 Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J Biomed Sci 2020;27:72. [PMID: 32498686 DOI: 10.1186/s12929-020-00663-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
499 Papadopoulos N, Vasileiadi S, Deutsch M. COVID-19 and liver injury: where do we stand? Ann Gastroenterol 2020;33:459-64. [PMID: 32879591 DOI: 10.20524/aog.2020.0522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
500 Day CW, Baric R, Cai SX, Frieman M, Kumaki Y, Morrey JD, Smee DF, Barnard DL. A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology 2009;395:210-22. [PMID: 19853271 DOI: 10.1016/j.virol.2009.09.023] [Cited by in Crossref: 94] [Cited by in F6Publishing: 97] [Article Influence: 7.2] [Reference Citation Analysis]
501 Ren L, Zhang Y, Li J, Xiao Y, Zhang J, Wang Y, Chen L, Paranhos-Baccalà G, Wang J. Genetic drift of human coronavirus OC43 spike gene during adaptive evolution. Sci Rep 2015;5:11451. [PMID: 26099036 DOI: 10.1038/srep11451] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
502 Fan W, Chen J, Zhang Y, Deng Q, Wei L, Zhao C, Lv D, Lin L, Zhang B, Wei T, Huang T, Wei P, Mo M. Phylogenetic and Spatiotemporal Analyses of the Complete Genome Sequences of Avian Coronavirus Infectious Bronchitis Virus in China During 1985-2020: Revealing Coexistence of Multiple Transmission Chains and the Origin of LX4-Type Virus. Front Microbiol 2022;13:693196. [PMID: 35444624 DOI: 10.3389/fmicb.2022.693196] [Reference Citation Analysis]
503 Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003;3:722-727. [PMID: 14592603 DOI: 10.1016/s1473-3099(03)00806-5] [Cited by in Crossref: 702] [Cited by in F6Publishing: 459] [Article Influence: 36.9] [Reference Citation Analysis]
504 Piombino P, Sani L, Committeri U, Carraturo E, Foderini A, Romano A, Orabona GD, Bonavolontà P, Abbate V, Califano L. Guidelines and Recommendations for Patient Management, Surgical Activities, and Safety in the Maxillofacial Unit and Head and Neck Department During COVID-19 Pandemic. J Craniofac Surg 2020;31:e630-3. [PMID: 32649560 DOI: 10.1097/SCS.0000000000006753] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
505 Mehmood I, Ijaz M, Ahmad S, Ahmed T, Bari A, Abro A, Allemailem KS, Almatroudi A, Tahir Ul Qamar M. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development. Int J Environ Res Public Health 2021;18:1626. [PMID: 33567746 DOI: 10.3390/ijerph18041626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
506 Hamidi Farahani R, Gholami M, Hazrati E, Hosseini Rouzbahani N, Hejripour Z, Soleiman-meigooni S, Dadmanesh M, Noorifard M, Kargar J, Motavalli F, Laripour R, Nourmohammadi A, Zargar S. Clinical Features of ICU Admitted and Intubated Novel Corona Virus-infected Patients in Iran. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.103295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
507 Nkengasong JN, Nsubuga P, Nwanyanwu O, Gershy-Damet GM, Roscigno G, Bulterys M, Schoub B, DeCock KM, Birx D. Laboratory systems and services are critical in global health: time to end the neglect? Am J Clin Pathol 2010;134:368-73. [PMID: 20716791 DOI: 10.1309/AJCPMPSINQ9BRMU6] [Cited by in Crossref: 109] [Cited by in F6Publishing: 79] [Article Influence: 9.1] [Reference Citation Analysis]
508 Tizaoui K, Zidi I, Lee KH, Ghayda RA, Hong SH, Li H, Smith L, Koyanagi A, Jacob L, Kronbichler A, Shin JI. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19). Int J Biol Sci 2020;16:2906-23. [PMID: 33061805 DOI: 10.7150/ijbs.48812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
509 Hemmati F, Hemmati-Dinarvand M, Karimzade M, Rutkowska D, Eskandari MH, Khanizadeh S, Afsharifar A. Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2. Biotechnol Lett 2021. [PMID: 34837582 DOI: 10.1007/s10529-021-03211-0] [Reference Citation Analysis]
510 Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, Guo D. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci U S A 2009;106:3484-9. [PMID: 19208801 DOI: 10.1073/pnas.0808790106] [Cited by in Crossref: 216] [Cited by in F6Publishing: 197] [Article Influence: 16.6] [Reference Citation Analysis]
511 Kao RY, Tsui WH, Lee TS, Tanner JA, Watt RM, Huang JD, Hu L, Chen G, Chen Z, Zhang L, He T, Chan KH, Tse H, To AP, Ng LW, Wong BC, Tsoi HW, Yang D, Ho DD, Yuen KY. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol 2004;11:1293-9. [PMID: 15380189 DOI: 10.1016/j.chembiol.2004.07.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 6.1] [Reference Citation Analysis]
512 Zhuang M, Jiang H, Suzuki Y, Li X, Xiao P, Tanaka T, Ling H, Yang B, Saitoh H, Zhang L, Qin C, Sugamura K, Hattori T. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res 2009;82:73-81. [PMID: 19428598 DOI: 10.1016/j.antiviral.2009.02.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
513 Adedeji IA, Abdu YM, Bashir MF, Adamu AS, Gwarzo GD, Yaro BS, Musa AA, Hassan ZI, Maigoro AM, Jibrin YB. Profile of children with COVID-19 infection: a cross sectional study from North-East Nigeria. Pan Afr Med J 2020;35:145. [PMID: 33193960 DOI: 10.11604/pamj.supp.2020.35.145.25350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
514 Savtale S, Hippargekar P, Bhise S, Kothule S. Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients. Indian J Otolaryngol Head Neck Surg 2021;:1-7. [PMID: 33585177 DOI: 10.1007/s12070-021-02410-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
515 Caruana G, Croxatto A, Coste AT, Opota O, Lamoth F, Jaton K, Greub G. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clin Microbiol Infect 2020;26:1178-82. [PMID: 32593741 DOI: 10.1016/j.cmi.2020.06.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 35.0] [Reference Citation Analysis]
516 Symvoulakis EK, Karageorgiou I, Linardakis M, Papagiannis D, Hatzoglou C, Symeonidis A, Rachiotis G. Knowledge, Attitudes, and Practices of Primary Care Physicians towards COVID-19 in Greece: A Cross-Sectional Study. Healthcare 2022;10:545. [DOI: 10.3390/healthcare10030545] [Reference Citation Analysis]
517 Feng D, de Vlas SJ, Fang LQ, Han XN, Zhao WJ, Sheng S, Yang H, Jia ZW, Richardus JH, Cao WC. The SARS epidemic in mainland China: bringing together all epidemiological data. Trop Med Int Health 2009;14 Suppl 1:4-13. [PMID: 19508441 DOI: 10.1111/j.1365-3156.2008.02145.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
518 Randhawa GS, Soltysiak MPM, El Roz H, de Souza CPE, Hill KA, Kari L. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. PLoS One 2020;15:e0232391. [PMID: 32330208 DOI: 10.1371/journal.pone.0232391] [Cited by in Crossref: 300] [Cited by in F6Publishing: 78] [Article Influence: 150.0] [Reference Citation Analysis]
519 Wallace LA, Collins TC, Douglas JD, McIntyre S, Millar J, Carman WF. Virological surveillance of influenza-like illness in the community using PCR and serology. J Clin Virol 2004;31:40-5. [PMID: 15288612 DOI: 10.1016/j.jcv.2003.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
520 Annan A, Owusu M, Marfo KS, Larbi R, Sarpong FN, Adu-Sarkodie Y, Amankwa J, Fiafemetsi S, Drosten C, Owusu-Dabo E, Eckerle I. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health 2015;20:807-12. [PMID: 25688471 DOI: 10.1111/tmi.12482] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
521 Galvani AP, Lei X, Jewell NP. Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerg Infect Dis 2003;9:991-4. [PMID: 12967499 DOI: 10.3201/eid0908.030334] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
522 . EMERGING RESPIRATORY DISEASE - CORONAVIRUSES. Dis Mon 2017;63:256-62. [PMID: 29737283 DOI: 10.1016/j.disamonth.2017.03.019] [Reference Citation Analysis]
523 Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol 2005;79:2678-88. [PMID: 15708987 DOI: 10.1128/JVI.79.5.2678-2688.2005] [Cited by in Crossref: 147] [Cited by in F6Publishing: 120] [Article Influence: 8.6] [Reference Citation Analysis]
524 Kim HJ. Novel respiratory infectious diseases in Korea. Yeungnam Univ J Med 2020;37:286-95. [PMID: 33045803 DOI: 10.12701/yujm.2020.00633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
525 Gong YN, Tsao KC, Hsiao MJ, Huang CG, Huang PN, Huang PW, Lee KM, Liu YC, Yang SL, Kuo RL, Chen KF, Liu YC, Huang SY, Huang HI, Liu MT, Yang JR, Chiu CH, Yang CT, Chen GW, Shih SR. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East. Emerg Microbes Infect 2020;9:1457-66. [PMID: 32543353 DOI: 10.1080/22221751.2020.1782271] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 32.5] [Reference Citation Analysis]
526 Shi J, Wei Z, Song J. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J Biol Chem 2004;279:24765-73. [PMID: 15037623 DOI: 10.1074/jbc.M311744200] [Cited by in Crossref: 111] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
527 Ye W, Ye X, Liu Y, Liu Q, Vafaei S, Gao Y, Yu H, Zhong Y, Zhan C. Effect of the Novel Coronavirus Pneumonia Pandemic on Medical Students' Psychological Stress and Its Influencing Factors. Front Psychol 2020;11:548506. [PMID: 33178063 DOI: 10.3389/fpsyg.2020.548506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
528 Petrenko VA, Gillespie JW, De Plano LM, Shokhen MA. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors. Viruses 2022;14:384. [DOI: 10.3390/v14020384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Muradrasoli S, Mohamed N, Hornyák A, Fohlman J, Olsen B, Belák S, Blomberg J. Broadly targeted multiprobe QPCR for detection of coronaviruses: Coronavirus is common among mallard ducks (Anas platyrhynchos). J Virol Methods 2009;159:277-87. [PMID: 19406168 DOI: 10.1016/j.jviromet.2009.04.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
530 Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol 2021;52:123-34. [PMID: 34915287 DOI: 10.1016/j.coviro.2021.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
531 Sharif-Yakan A, Kanj SS. Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLoS Pathog 2014;10:e1004457. [PMID: 25474536 DOI: 10.1371/journal.ppat.1004457] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
532 Zuwała K, Golda A, Kabala W, Burmistrz M, Zdzalik M, Nowak P, Kedracka-Krok S, Zarebski M, Dobrucki J, Florek D, Zeglen S, Wojarski J, Potempa J, Dubin G, Pyrc K. The nucleocapsid protein of human coronavirus NL63. PLoS One 2015;10:e0117833. [PMID: 25700263 DOI: 10.1371/journal.pone.0117833] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
533 van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol 2005;79:1635-44. [PMID: 15650189 DOI: 10.1128/JVI.79.3.1635-1644.2005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
534 Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol 2004;78:6938-45. [PMID: 15194770 DOI: 10.1128/JVI.78.13.6938-6945.2004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
535 Kim JM, Jung HD, Cheong HM, Lee A, Lee NJ, Chu H, Lee JY, Kim SS, Choi JH. Nation-wide surveillance of human acute respiratory virus infections between 2013 and 2015 in Korea. J Med Virol 2018;90:1177-83. [PMID: 29488229 DOI: 10.1002/jmv.25069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
536 Rinninger A, Richet C, Pons A, Kohla G, Schauer R, Bauer HC, Zanetta JP, Vlasak R. Localisation and distribution of O-acetylated N-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterases of murine coronaviruses, in mouse tissue. Glycoconj J 2006;23:73-84. [PMID: 16575524 DOI: 10.1007/s10719-006-5439-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
537 Vicenzi E, Canducci F, Pinna D, Mancini N, Carletti S, Lazzarin A, Bordignon C, Poli G, Clementi M. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis 2004;10:413-8. [PMID: 15109406 DOI: 10.3201/eid1003.030683] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
538 Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Van Ranst M. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int J Infect Dis 2004;8:223-6. [PMID: 15234326 DOI: 10.1016/j.ijid.2004.04.012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
539 Reguera J, Ordoño D, Santiago C, Enjuanes L, Casasnovas JM. Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein. J Gen Virol. 2011;92:1117-1126. [PMID: 21228126 DOI: 10.1099/vir.0.027607-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
540 van der Meer FJ, de Haan CA, Schuurman NM, Haijema BJ, Peumans WJ, Van Damme EJ, Delputte PL, Balzarini J, Egberink HF. Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture. Antiviral Res 2007;76:21-9. [PMID: 17560666 DOI: 10.1016/j.antiviral.2007.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
541 Tsai MH, Lin TY, Chiu CH, Lin PY, Huang YC, Tsao KC, Huang CG, Hsu KH, Lin MC, Hwang KP, Yang KD. Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. J Formos Med Assoc 2008;107:885-91. [PMID: 18971158 DOI: 10.1016/S0929-6646(08)60205-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
542 Guglielmi V, Colangeli L, D'Adamo M, Sbraccia P. Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? Int J Mol Sci 2021;22:3183. [PMID: 33804765 DOI: 10.3390/ijms22063183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
543 Gomes BPFA, Arruda-Vasconcelos R, Louzada LM, Almeida-Gomes RF, de-Jesus-Soares A, Almeida LRF, Baldacci ER. SARS-CoV-2: A Professional and social gamechanger - Medical and dental aspects. Braz Dent J 2021;32:41-54. [PMID: 34877977 DOI: 10.1590/0103-6440202104144] [Reference Citation Analysis]
544 El-Shehawi AM, Alotaibi SS, Elseehy MM. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms. Cytol Genet 2020;54:588-604. [PMID: 33487779 DOI: 10.3103/S0095452720060031] [Reference Citation Analysis]
545 Tambyah PA. SARS: responding to an unknown virus. Eur J Clin Microbiol Infect Dis 2004;23:589-95. [PMID: 15252720 DOI: 10.1007/s10096-004-1175-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
546 Kommoss FKF, Schwab C, Tavernar L, Schreck J, Wagner WL, Merle U, Jonigk D, Schirmacher P, Longerich T. The Pathology of Severe COVID-19-Related Lung Damage. Dtsch Arztebl Int 2020;117:500-6. [PMID: 32865490 DOI: 10.3238/arztebl.2020.0500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
547 Hernandez-Alias X, Benisty H, Schaefer MH, Serrano L. Translational adaptation of human viruses to the tissues they infect. Cell Rep 2021;34:108872. [PMID: 33730572 DOI: 10.1016/j.celrep.2021.108872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
548 Xiao X, Wang C, Chang, Wang Y, Dong X, Jiao T, Zhao Z, Ren L, Dela Cruz CS, Sharma L, Lei X, Wang J. Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Front Immunol 2020;11:586572. [PMID: 33324406 DOI: 10.3389/fimmu.2020.586572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
549 Hui DS, Chan MC, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J 2004;80:373-81. [PMID: 15254300 DOI: 10.1136/pgmj.2004.020263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
550 Li T, Zhang Y, Fu L, Yu C, Li X, Li Y, Zhang X, Rong Z, Wang Y, Ning H. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. Gene Ther. 2005;12:751-761. [PMID: 15772689 DOI: 10.1038/sj.gt.3302479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
551 He J, Tao H, Yan Y, Huang SY, Xiao Y. Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. Viruses 2020;12:E428. [PMID: 32290077 DOI: 10.3390/v12040428] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 34.5] [Reference Citation Analysis]
552 Wang L, Xiang Y. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses. Viruses 2020;12:E1289. [PMID: 33187074 DOI: 10.3390/v12111289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
553 Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, McEvoy CP, Hayden CD, Fukuoka J, Taubenberger JK, Travis WD. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003;34:743-8. [PMID: 14506633 DOI: 10.1016/s0046-8177(03)00367-8] [Cited by in Crossref: 267] [Cited by in F6Publishing: 196] [Article Influence: 14.1] [Reference Citation Analysis]
554 Lee TW, Cherney MM, Liu J, James KE, Powers JC, Eltis LD, James MN. Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase. J Mol Biol 2007;366:916-32. [PMID: 17196984 DOI: 10.1016/j.jmb.2006.11.078] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
555 Shaban MS, Müller C, Mayr-Buro C, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, Karl N, Hofmann N, Becker S, Herold S, Schmitz ML, Ziebuhr J, Kracht M. Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun 2021;12:5536. [PMID: 34545074 DOI: 10.1038/s41467-021-25551-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
556 Balzarini J, Keyaerts E, Vijgen L, Egberink H, De Clercq E, Van Ranst M, Printsevskaya SS, Olsufyeva EN, Solovieva SE, Preobrazhenskaya MN. Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. Antiviral Res 2006;72:20-33. [PMID: 16675038 DOI: 10.1016/j.antiviral.2006.03.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
557 Davis BM, Foxman B, Monto AS, Baric RS, Martin ET, Uzicanin A, Rainey JJ, Aiello AE. Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding. Influenza Other Respir Viruses 2018;12:582-90. [PMID: 29660826 DOI: 10.1111/irv.12563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
558 Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 Lineage. J Mol Biol. 2003;331:991-1004. [PMID: 12927536 DOI: 10.1016/s0022-2836(03)00865-9] [Cited by in Crossref: 829] [Cited by in F6Publishing: 671] [Article Influence: 43.6] [Reference Citation Analysis]
559 Fukushi M, Yoshinaka Y, Matsuoka Y, Hatakeyama S, Ishizaka Y, Kirikae T, Sasazuki T, Miyoshi-Akiyama T. Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus. J Virol 2012;86:11745-53. [PMID: 22915798 DOI: 10.1128/JVI.01250-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
560 Yoo HM, Kim IH, Kim S. Nucleic Acid Testing of SARS-CoV-2. Int J Mol Sci 2021;22:6150. [PMID: 34200331 DOI: 10.3390/ijms22116150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis 2020;94:44-8. [PMID: 32171952 DOI: 10.1016/j.ijid.2020.03.004] [Cited by in Crossref: 399] [Cited by in F6Publishing: 325] [Article Influence: 199.5] [Reference Citation Analysis]
562 Xue-zhe Z, Wu W, Yan L, Zhen-guo H, Wen H, Yan-ning S, An R. CT manifestations of lung changes and complications in patients with severe acute respiratory syndrome. Chin J Integr Med 2003;9:254-8. [DOI: 10.1007/bf02838608] [Reference Citation Analysis]
563 Melzow F, Mertens S, Todorov H, Groneberg DA, Paris S, Gerber A. Aerosol exposure of staff during dental treatments: a model study. BMC Oral Health 2022;22. [DOI: 10.1186/s12903-022-02155-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
564 Meyers C, Kass R, Goldenberg D, Milici J, Alam S, Robison R. Ethanol and isopropanol inactivation of human coronavirus on hard surfaces. J Hosp Infect 2021;107:45-9. [PMID: 32991941 DOI: 10.1016/j.jhin.2020.09.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
565 Bartlam M, Xu Y, Rao Z. Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases. J Struct Funct Genomics 2007;8:85-97. [PMID: 17680348 DOI: 10.1007/s10969-007-9024-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
566 Kaddoura M, AlIbrahim M, Hijazi G, Soudani N, Audi A, Alkalamouni H, Haddad S, Eid A, Zaraket H. COVID-19 Therapeutic Options Under Investigation. Front Pharmacol 2020;11:1196. [PMID: 32848795 DOI: 10.3389/fphar.2020.01196] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
567 Spiegel M, Pichlmair A, Martínez-Sobrido L, Cros J, García-Sastre A, Haller O, Weber F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol. 2005;79:2079-2086. [PMID: 15681410 DOI: 10.1128/JVI.79.4.2079-2086.2005] [Cited by in Crossref: 211] [Cited by in F6Publishing: 163] [Article Influence: 12.4] [Reference Citation Analysis]
568 Wilson L, McKinlay C, Gage P, Ewart G. SARS coronavirus E protein forms cation-selective ion channels. Virology 2004;330:322-31. [PMID: 15527857 DOI: 10.1016/j.virol.2004.09.033] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 10.3] [Reference Citation Analysis]
569 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
570 Cheung TM, Yam LY, So LK, Lau AC, Poon E, Kong BM, Yung RW. Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest 2004;126:845-50. [PMID: 15364765 DOI: 10.1378/chest.126.3.845] [Cited by in Crossref: 118] [Cited by in F6Publishing: 75] [Article Influence: 6.6] [Reference Citation Analysis]
571 Chen IY, Chang SC, Wu HY, Yu TC, Wei WC, Lin S, Chien CL, Chang MF. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol 2010;84:7703-12. [PMID: 20484496 DOI: 10.1128/JVI.02560-09] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
572 Lu X, Chen Y, Bai B, Hu H, Tao L, Yang J, Chen J, Chen Z, Hu Z, Wang H. Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology 2007;122:496-502. [PMID: 17680799 DOI: 10.1111/j.1365-2567.2007.02676.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
573 Miszczak F, Tesson V, Kin N, Dina J, Balasuriya UB, Pronost S, Vabret A. First detection of equine coronavirus (ECoV) in Europe. Vet Microbiol 2014;171:206-9. [PMID: 24768449 DOI: 10.1016/j.vetmic.2014.03.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
574 Wang Y, Zhou Y, Yang Z, Xia D, Hu Y, Geng S. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China. Respiration 2020;99:649-57. [PMID: 32841948 DOI: 10.1159/000507940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
575 Ma Y, Feng Y, Liu D, Gao GF. Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratory syndrome-coronavirus and beyond: molecular epidemiology, ecology and the situation in China. Philos Trans R Soc Lond B Biol Sci 2009;364:2725-37. [PMID: 19687041 DOI: 10.1098/rstb.2009.0093] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
576 Arora M, Tuchen S, Nazemi M, Blessing L. Airport Pandemic Response: An Assessment of Impacts and Strategies after One Year with COVID-19. Transp Res Interdiscip Perspect 2021;:100449. [PMID: 34458721 DOI: 10.1016/j.trip.2021.100449] [Reference Citation Analysis]
577 Li X, Hou P, Ma W, Wang X, Wang H, Yu Z, Chang H, Wang T, Jin S, Wang X, Wang W, Zhao Y, Zhao Y, Xu C, Ma X, Gao Y, He H. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol 2021. [PMID: 34845370 DOI: 10.1038/s41423-021-00807-4] [Reference Citation Analysis]
578 Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 2005;79:15511-24. [PMID: 16306622 DOI: 10.1128/JVI.79.24.15511-15524.2005] [Cited by in Crossref: 205] [Cited by in F6Publishing: 151] [Article Influence: 12.8] [Reference Citation Analysis]
579 Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health 2020;8:152. [PMID: 32411652 DOI: 10.3389/fpubh.2020.00152] [Cited by in Crossref: 636] [Cited by in F6Publishing: 565] [Article Influence: 318.0] [Reference Citation Analysis]
580 Dong Y, Shamsuddin A, Campbell H, Theodoratou E. Current COVID-19 treatments: Rapid review of the literature. J Glob Health 2021;11:10003. [PMID: 33959261 DOI: 10.7189/jogh.11.10003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
581 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
582 Milanetti E, Miotto M, Di Rienzo L, Nagaraj M, Monti M, Golbek TW, Gosti G, Roeters SJ, Weidner T, Otzen DE, Ruocco G. In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2. Front Mol Biosci 2021;8:690655. [PMID: 34179095 DOI: 10.3389/fmolb.2021.690655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW, Soo YO, Chiu ML, Chan YS, Hui D, Lee N, Wu A, Leung CB, Sung JJ. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J 2006;82:140-4. [PMID: 16461478 DOI: 10.1136/pgmj.2005.037515] [Cited by in Crossref: 180] [Cited by in F6Publishing: 170] [Article Influence: 11.3] [Reference Citation Analysis]
584 Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology 2009;393:265-71. [PMID: 19717178 DOI: 10.1016/j.virol.2009.07.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
585 Zawawi A, Alghanmi M, Alsaady I, Gattan H, Zakai H, Couper K. The impact of COVID-19 pandemic on malaria elimination. Parasite Epidemiol Control 2020;11:e00187. [PMID: 33102823 DOI: 10.1016/j.parepi.2020.e00187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
586 Fang X, Gao J, Zheng H, Li B, Kong L, Zhang Y, Wang W, Zeng Y, Ye L. The membrane protein of SARS-CoV suppresses NF-kappaB activation. J Med Virol 2007;79:1431-9. [PMID: 17705188 DOI: 10.1002/jmv.20953] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
587 Casas I, Pozo F. [SARS, avian influenza, and human metapneumovirus infection]. Enferm Infecc Microbiol Clin 2005;23:438-47, quiz 448. [PMID: 16159544 DOI: 10.1157/13078803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
588 MacNamara KC, Chua MM, Phillips JJ, Weiss SR. Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence. J Virol 2005;79:9108-18. [PMID: 15994805 DOI: 10.1128/JVI.79.14.9108-9118.2005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
589 Shrestha A, Thapa TB, Giri M, Kumar S, Dhobi S, Thapa H, Dhami PP, Shahi A, Ghimire A, Rathaur ES. Knowledge and attitude on prevention of COVID-19 among community health workers in Nepal-a cross-sectional study. BMC Public Health 2021;21:1424. [PMID: 34281512 DOI: 10.1186/s12889-021-11400-9] [Reference Citation Analysis]
590 Lu HY, Xu XY, Lei Y, Wu YF, Chen BW, Xiao F, Xie GQ, Han DM. Characteristics of 1 062 patients with SARS in early stage in Beijing. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1149-1154 [DOI: 10.11569/wcjd.v12.i5.1149] [Reference Citation Analysis]
591 Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 2014;807:75-96. [PMID: 24619619 DOI: 10.1007/978-81-322-1777-0_6] [Cited by in Crossref: 129] [Cited by in F6Publishing: 124] [Article Influence: 16.1] [Reference Citation Analysis]
592 Calabrò L, Rossi G, Covre A, Morra A, Maio M. COVID and Lung Cancer. Curr Oncol Rep 2021;23:134. [PMID: 34677721 DOI: 10.1007/s11912-021-01125-8] [Reference Citation Analysis]
593 Hennrich AA, Sawatsky B, Santos-Mandujano R, Banda DH, Oberhuber M, Schopf A, Pfaffinger V, Wittwer K, Riedel C, Pfaller CK, Conzelmann KK. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization. PLoS Pathog 2021;17:e1009064. [PMID: 33882114 DOI: 10.1371/journal.ppat.1009064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
594 Alsoussi WB, Turner JS, Case JB, Zhao H, Schmitz AJ, Zhou JQ, Chen RE, Lei T, Rizk AA, McIntire KM, Winkler ES, Fox JM, Kafai NM, Thackray LB, Hassan AO, Amanat F, Krammer F, Watson CT, Kleinstein SH, Fremont DH, Diamond MS, Ellebedy AH. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol 2020;205:915-22. [PMID: 32591393 DOI: 10.4049/jimmunol.2000583] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 48.5] [Reference Citation Analysis]
595 Kabay G, DeCastro J, Altay A, Smith K, Lu HW, Capossela AM, Moarefian M, Aran K, Dincer C. Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases. Adv Mater 2022;:e2201085. [PMID: 35288985 DOI: 10.1002/adma.202201085] [Reference Citation Analysis]
596 Blume C, Jackson CL, Spalluto CM, Legebeke J, Nazlamova L, Conforti F, Perotin JM, Frank M, Butler J, Crispin M, Coles J, Thompson J, Ridley RA, Dean LSN, Loxham M, Reikine S, Azim A, Tariq K, Johnston DA, Skipp PJ, Djukanovic R, Baralle D, McCormick CJ, Davies DE, Lucas JS, Wheway G, Mennella V. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet 2021;53:205-14. [PMID: 33432184 DOI: 10.1038/s41588-020-00759-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 23.0] [Reference Citation Analysis]
597 Algaissi AA, Alharbi NK, Hassanain M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience. J Infect Public Health 2020;13:834-8. [PMID: 32451260 DOI: 10.1016/j.jiph.2020.04.016] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 36.5] [Reference Citation Analysis]
598 Lei J, Hilgenfeld R. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin. Virol Sin 2016;31:288-99. [PMID: 27245450 DOI: 10.1007/s12250-016-3742-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
599 Wang F, Chen C, Wang Z, Han X, Shi P, Zhou K, Liu X, Xiao Y, Cai Y, Huang J, Zhang L, Yang H. The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals. Viruses 2022;14:486. [DOI: 10.3390/v14030486] [Reference Citation Analysis]
600 Hussein M, Andrade dos Ramos Z, Berkhout B, Herrera-carrillo E. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack. Viruses 2022;14:385. [DOI: 10.3390/v14020385] [Reference Citation Analysis]
601 Briguglio I, Piras S, Corona P, Carta A. Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families. Int J Med Chem 2011;2011:213135. [PMID: 27516903 DOI: 10.1155/2011/213135] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
602 Loeb M, McGeer A, Henry B, Ofner M, Rose D, Hlywka T, Levie J, McQueen J, Smith S, Moss L, Smith A, Green K, Walter SD. SARS among critical care nurses, Toronto. Emerg Infect Dis 2004;10:251-5. [PMID: 15030692 DOI: 10.3201/eid1002.030838] [Cited by in Crossref: 202] [Cited by in F6Publishing: 193] [Article Influence: 11.2] [Reference Citation Analysis]
603 Maheden K, Todd B, Gordon CJ, Tchesnokov EP, Götte M. Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs. Enzymes 2021;49:315-54. [PMID: 34696837 DOI: 10.1016/bs.enz.2021.07.002] [Reference Citation Analysis]
604 Hui DS, Chan PK. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010;24:619-38. [PMID: 20674795 DOI: 10.1016/j.idc.2010.04.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
605 Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cervero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Front Immunol 2021;12:742631. [PMID: 34616404 DOI: 10.3389/fimmu.2021.742631] [Reference Citation Analysis]
606 Navas-Martin S, Hingley ST, Weiss SR. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J Virol 2005;79:7629-40. [PMID: 15919915 DOI: 10.1128/JVI.79.12.7629-7640.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
607 Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review. Biol Proced Online 2020;22:15. [PMID: 32754003 DOI: 10.1186/s12575-020-00129-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
608 Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA;  KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-416. [PMID: 23782161 DOI: 10.1056/nejmoa1306742] [Cited by in Crossref: 782] [Cited by in F6Publishing: 610] [Article Influence: 86.9] [Reference Citation Analysis]
609 Nieto-Torres JL, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, Torres J, Aguilella VM, Enjuanes L. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 2015;485:330-9. [PMID: 26331680 DOI: 10.1016/j.virol.2015.08.010] [Cited by in Crossref: 208] [Cited by in F6Publishing: 190] [Article Influence: 29.7] [Reference Citation Analysis]
610 Chen Z, Pei D, Jiang L, Song Y, Wang J, Wang H, Zhou D, Zhai J, Du Z, Li B, Qiu M, Han Y, Guo Z, Yang R. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 2004;50:988-95. [PMID: 15054081 DOI: 10.1373/clinchem.2004.031096] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
611 Spruth M, Kistner O, Savidis-Dacho H, Hitter E, Crowe B, Gerencer M, Brühl P, Grillberger L, Reiter M, Tauer C, Mundt W, Barrett PN. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. Vaccine 2006;24:652-61. [PMID: 16214268 DOI: 10.1016/j.vaccine.2005.08.055] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
612 van Elden LJ, van Loon AM, van Alphen F, Hendriksen KA, Hoepelman AI, van Kraaij MG, Oosterheert JJ, Schipper P, Schuurman R, Nijhuis M. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004;189:652-7. [PMID: 14767819 DOI: 10.1086/381207] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 7.7] [Reference Citation Analysis]
613 Bossi P, Guihot A, Ansart S, Bricaire F. [Severe acute respiratory syndrome: update]. Rev Med Interne 2003;24:672-80. [PMID: 14550520 DOI: 10.1016/s0248-8663(03)00262-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
614 Lee CC, Kuo CJ, Ko TP, Hsu MF, Tsui YC, Chang SC, Yang S, Chen SJ, Chen HC, Hsu MC. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem. 2009;284:7646-7655. [PMID: 19144641 DOI: 10.1074/jbc.M807947200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
615 Gorain B, Choudhury H, Molugulu N, Athawale RB, Kesharwani P. Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy. Front Public Health 2020;8:606129. [PMID: 33363098 DOI: 10.3389/fpubh.2020.606129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
616 Verma RK, Kannaujia S, Khurana N, Singh A, Singh DP, Kumar A. Clinical correlation of severe acute respiratory syndrome-coronavirus-2 cases in selected districts of Uttar Pradesh: A cross-sectional hospital-based study. J Educ Health Promot 2020;9:357. [PMID: 33575393 DOI: 10.4103/jehp.jehp_563_20] [Reference Citation Analysis]
617 Armijos-Jaramillo V, Yeager J, Muslin C, Perez-Castillo Y. SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability. Evol Appl 2020. [PMID: 32837536 DOI: 10.1111/eva.12980] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
618 Koopmans M. Surveillance strategy for early detection of unusual infectious disease events. Curr Opin Virol 2013;3:185-91. [PMID: 23612329 DOI: 10.1016/j.coviro.2013.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
619 Shan D, Tang X, Liu R, Pan D, Wang X, Ge J, Wen Z, Bu Z. Immunogenicity of a Recombinant VSV-Vectored SARS-CoV Vaccine Induced Robust Immunity in Rhesus Monkeys after Single-Dose Immunization. Virologica Sinica 2022. [DOI: 10.1016/j.virs.2022.01.002] [Reference Citation Analysis]
620 Janik E, Bartos M, Niemcewicz M, Gorniak L, Bijak M. SARS-CoV-2: Outline, Prevention, and Decontamination. Pathogens 2021;10:114. [PMID: 33498679 DOI: 10.3390/pathogens10020114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
621 Porras-Villamil JF, Olivera MJ, Ríos-Camargo NK. The First Few Hundred Cases for Coronavirus Disease 2019 (COVID-19) in Colombia. Iran J Public Health 2020;49:48-56. [PMID: 34268205 DOI: 10.18502/ijph.v49iS1.3669] [Reference Citation Analysis]
622 Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F. Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway. J Virol 2008;82:588-92. [PMID: 17942557 DOI: 10.1128/JVI.01697-07] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
623 Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology 2020;551:1-9. [PMID: 33010669 DOI: 10.1016/j.virol.2020.08.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
624 Zhao GP. SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci 2007;362:1063-81. [PMID: 17327210 DOI: 10.1098/rstb.2007.2034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
625 Schaecher SR, Mackenzie JM, Pekosz A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol 2007;81:718-31. [PMID: 17079322 DOI: 10.1128/JVI.01691-06] [Cited by in Crossref: 101] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
626 Yoshizawa SI, Hattori Y, Kobayashi K, Akaji K. Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor. Bioorg Med Chem 2020;28:115273. [PMID: 31926775 DOI: 10.1016/j.bmc.2019.115273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
627 Huang C, Liu WJ, Xu W, Jin T, Zhao Y, Song J, Shi Y, Ji W, Jia H, Zhou Y, Wen H, Zhao H, Liu H, Li H, Wang Q, Wu Y, Wang L, Liu D, Liu G, Yu H, Holmes EC, Lu L, Gao GF. A Bat-Derived Putative Cross-Family Recombinant Coronavirus with a Reovirus Gene. PLoS Pathog 2016;12:e1005883. [PMID: 27676249 DOI: 10.1371/journal.ppat.1005883] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
628 Chunling M, Kun Y, Jian X, Jian Q, Hua S, Minsheng Z. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice. Intervirology 2006;49:307-18. [PMID: 16809936 DOI: 10.1159/000094247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
629 Barros IN, Silva SO, Nogueira Neto FS, Asano KM, Souza SP, Richtzenhain LJ, Brandao PE. A multigene approach for comparing genealogy of Betacoronavirus from cattle and horses. ScientificWorldJournal 2013;2013:349702. [PMID: 24348152 DOI: 10.1155/2013/349702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
630 Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang YW, Widen R, Drews SJ. Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections. Clin Microbiol Rev 2019;32:e00042-18. [PMID: 30541871 DOI: 10.1128/CMR.00042-18] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
631 Geraghty RJ, Aliota MT, Bonnac LF. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses 2021;13:667. [PMID: 33924302 DOI: 10.3390/v13040667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
632 Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Günther S, Drosten C, Michiels T, Staeheli P. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 2010;84:5670-7. [PMID: 20335250 DOI: 10.1128/JVI.00272-10] [Cited by in Crossref: 269] [Cited by in F6Publishing: 195] [Article Influence: 22.4] [Reference Citation Analysis]
633 Pfefferle S, Oppong S, Drexler JF, Gloza-Rausch F, Ipsen A, Seebens A, Müller MA, Annan A, Vallo P, Adu-Sarkodie Y, Kruppa TF, Drosten C. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis 2009;15:1377-84. [PMID: 19788804 DOI: 10.3201/eid1509.090224] [Cited by in Crossref: 163] [Cited by in F6Publishing: 144] [Article Influence: 13.6] [Reference Citation Analysis]
634 Chen CN, Lin CP, Huang KK, Chen WC, Hsieh HP, Liang PH, Hsu JT. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evid Based Complement Alternat Med 2005;2:209-15. [PMID: 15937562 DOI: 10.1093/ecam/neh081] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
635 Chowell G, Fenimore PW, Castillo-Garsow MA, Castillo-Chavez C. SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J Theor Biol 2003;224:1-8. [PMID: 12900200 DOI: 10.1016/s0022-5193(03)00228-5] [Cited by in Crossref: 162] [Cited by in F6Publishing: 64] [Article Influence: 8.5] [Reference Citation Analysis]
636 Haagmans BL, Osterhaus AD. Coronaviruses and their therapy. Antiviral Res 2006;71:397-403. [PMID: 16837072 DOI: 10.1016/j.antiviral.2006.05.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
637 Ewig S. [SARS. A lesson in infection epidemiology and a masterpiece of modern infection control]. Pathologe 2003;24:335-7. [PMID: 12961021 DOI: 10.1007/s00292-003-0637-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
638 Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons from SARS: control of acute lung failure by the SARS receptor ACE2. J Mol Med (Berl) 2006;84:814-20. [PMID: 16988814 DOI: 10.1007/s00109-006-0094-9] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
639 Ma Y, Tong X, Xu X, Li X, Lou Z, Rao Z. Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus. Protein Cell 2010;1:688-97. [PMID: 21203940 DOI: 10.1007/s13238-010-0079-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
640 Yuan X, Wu J, Shan Y, Yao Z, Dong B, Chen B, Zhao Z, Wang S, Chen J, Cong Y. SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via the cyclin D3/pRb pathway. Virology 2006;346:74-85. [PMID: 16303160 DOI: 10.1016/j.virol.2005.10.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
641 Zhou H, Yang J, Zhou C, Chen B, Fang H, Chen S, Zhang X, Wang L, Zhang L. A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV. Front Med (Lausanne) 2021;8:628370. [PMID: 34950674 DOI: 10.3389/fmed.2021.628370] [Reference Citation Analysis]
642 Greenough TC, Carville A, Coderre J, Somasundaran M, Sullivan JL, Luzuriaga K, Mansfield K. Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am J Pathol. 2005;167:455-463. [PMID: 16049331 DOI: 10.1016/s0002-9440(10)62989-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 4.2] [Reference Citation Analysis]
643 Gloza-Rausch F, Ipsen A, Seebens A, Göttsche M, Panning M, Drexler JF, Petersen N, Annan A, Grywna K, Müller M, Pfefferle S, Drosten C. Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg Infect Dis 2008;14:626-31. [PMID: 18400147 DOI: 10.3201/eid1404.071439] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 8.3] [Reference Citation Analysis]
644 Li X, Wang W, Zhao X, Zai J, Zhao Q, Li Y, Chaillon A. Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol 2020;92:501-11. [PMID: 32027035 DOI: 10.1002/jmv.25701] [Cited by in Crossref: 137] [Cited by in F6Publishing: 112] [Article Influence: 68.5] [Reference Citation Analysis]
645 Tsabouri S, Makis A, Kosmeri C, Siomou E. Risk Factors for Severity in Children with Coronavirus Disease 2019: A Comprehensive Literature Review. Pediatr Clin North Am 2021;68:321-38. [PMID: 33228941 DOI: 10.1016/j.pcl.2020.07.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
646 Bailey-Elkin BA, Knaap RCM, Kikkert M, Mark BL. Structure and Function of Viral Deubiquitinating Enzymes. J Mol Biol 2017;429:3441-70. [PMID: 28625850 DOI: 10.1016/j.jmb.2017.06.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
647 Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, Dumanov JM, Tutelyan VA, Onischenko GG, Aschner M, Spandidos DA, Calina D. A new threat from an old enemy: Re‑emergence of coronavirus (Review). Int J Mol Med 2020;45:1631-43. [PMID: 32236624 DOI: 10.3892/ijmm.2020.4555] [Cited by in Crossref: 30] [Cited by in F6Publishing: 92] [Article Influence: 15.0] [Reference Citation Analysis]
648 Wong CW, Albert TJ, Vega VB, Norton JE, Cutler DJ, Richmond TA, Stanton LW, Liu ET, Miller LD. Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res 2004;14:398-405. [PMID: 14993206 DOI: 10.1101/gr.2141004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 4.2] [Reference Citation Analysis]
649 Ding L, Zhang XX, Wei P, Fan K, Lai L. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis. Anal Biochem 2005;343:159-65. [PMID: 15935325 DOI: 10.1016/j.ab.2005.04.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
650 Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, Cai C, Lai K, Chen R, Chan-Yeung M, Zhong N. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 2006;11:49-53. [PMID: 16423201 DOI: 10.1111/j.1440-1843.2006.00783.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 7.9] [Reference Citation Analysis]
651 Hu W, Bai B, Hu Z, Chen Z, An X, Tang L, Yang J, Wang H, Wang H. Development and evaluation of a multitarget real-time Taqman reverse transcription-PCR assay for detection of the severe acute respiratory syndrome-associated coronavirus and surveillance for an apparently related coronavirus found in masked palm civets. J Clin Microbiol 2005;43:2041-6. [PMID: 15872219 DOI: 10.1128/JCM.43.5.2041-2046.2005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
652 Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C. Processing of the SARS-CoV pp1a/ab nsp7-10 region. Biochem J. 2020;477:1009-1019. [PMID: 32083638 DOI: 10.1042/bcj20200029] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 24.0] [Reference Citation Analysis]
653 Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int J Exp Pathol 2007;88:403-14. [PMID: 18039277 DOI: 10.1111/j.1365-2613.2007.00567.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
654 Huang SH, Lee TY, Lin YJ, Wan L, Lai CH, Lin CW. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism. J Microbiol Immunol Infect 2017;50:277-85. [PMID: 26320399 DOI: 10.1016/j.jmii.2015.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
655 Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS Pathog. 2013;9:e1003565. [PMID: 23966862 DOI: 10.1371/journal.ppat.1003565] [Cited by in Crossref: 231] [Cited by in F6Publishing: 207] [Article Influence: 25.7] [Reference Citation Analysis]
656 Abidha CA, Nyiro J, Kamau E, Abdullahi O, Nokes DJ, Agoti CN. Transmission and evolutionary dynamics of human coronavirus OC43 strains in coastal Kenya investigated by partial spike sequence analysis, 2015-16. Virus Evol 2020;6:veaa031. [PMID: 32523779 DOI: 10.1093/ve/veaa031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
657 Al Harthi S, Al Osali M, Al Ismaili R, Al Lawati S, Kamble B, Al Shaaibi M, Al Kindi N, Al Qasabi S, Alhinai M, Al Harthi H, Al Ghafri TS. Clinical Characteristics of Confirmed Cases of COVID-19 Admitted at Al Nahdha Hospital, Oman: A Cross-Sectional Descriptive Study. Cureus 2021;13:e17343. [PMID: 34567884 DOI: 10.7759/cureus.17343] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
658 Kapadia SU, Simon ID, Rose JK. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. Virology 2008;376:165-72. [PMID: 18396306 DOI: 10.1016/j.virol.2008.03.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
659 Tripet B, Howard MW, Jobling M, Holmes RK, Holmes KV, Hodges RS. Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 2004;279:20836-49. [PMID: 14996844 DOI: 10.1074/jbc.M400759200] [Cited by in Crossref: 148] [Cited by in F6Publishing: 116] [Article Influence: 8.2] [Reference Citation Analysis]
660 Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F. Inhibition of SARS-CoV-2 by type I and type III interferons. J Biol Chem 2020;295:13958-64. [PMID: 32587093 DOI: 10.1074/jbc.AC120.013788] [Cited by in Crossref: 84] [Cited by in F6Publishing: 50] [Article Influence: 42.0] [Reference Citation Analysis]
661 Abbas AT, El-Kafrawy SA, Sohrab SS, Azhar EIA. IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.Hum Vaccin Immunother. 2019;15:264-275. [PMID: 30230944 DOI: 10.1080/21645515.2018.1514224] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
662 Lee YC, Leu SJ, Hu CJ, Shih NY, Huang IJ, Wu HH, Hsieh WS, Chiang BL, Chiu WT, Yang YY. Chicken single-chain variable fragments against the SARS-CoV spike protein. J Virol Methods 2007;146:104-11. [PMID: 17643500 DOI: 10.1016/j.jviromet.2007.06.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
663 Surjit M, Liu B, Jameel S, Chow VT, Lal SK. The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem J 2004;383:13-8. [PMID: 15294014 DOI: 10.1042/BJ20040984] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 6.5] [Reference Citation Analysis]
664 Judson SD, Munster VJ. Editorial: Ecology and Evolution of Coronaviruses: Implications for Human Health. Front Public Health 2022;10:926677. [PMID: 35669756 DOI: 10.3389/fpubh.2022.926677] [Reference Citation Analysis]
665 Sørensen MD, Sørensen B, Gonzalez-Dosal R, Melchjorsen CJ, Weibel J, Wang J, Jun CW, Huanming Y, Kristensen P. Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals. Ann N Y Acad Sci. 2006;1067:500-505. [PMID: 16804033 DOI: 10.1196/annals.1354.072] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
666 Hu D, Lou X, Xu Z, Meng N, Xie Q, Zhang M, Zou Y, Liu J, Sun G, Wang F. More effective strategies are required to strengthen public awareness of COVID-19: Evidence from Google Trends. J Glob Health 2020;10:011003. [PMID: 32373339 DOI: 10.7189/jogh.10.011003] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
667 Marsden PA, Ning Q, Fung LS, Luo X, Chen Y, Mendicino M, Ghanekar A, Scott JA, Miller T, Chan CW. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 2003;112:58-66. [PMID: 12840059 DOI: 10.1172/jci18114] [Cited by in Crossref: 114] [Cited by in F6Publishing: 78] [Article Influence: 6.0] [Reference Citation Analysis]
668 Tardiolo G, Brianti P, Sapienza D, dell'Utri P, Dio VD, Rao G, Calabrò RS. Are We Paving the Way to Dig Out of the "Pandemic Hole"? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization. Med Sci (Basel) 2021;9:53. [PMID: 34449681 DOI: 10.3390/medsci9030053] [Reference Citation Analysis]
669 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(7): 881-887 [DOI: 10.11569/wcjd.v11.i7.881] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
670 Napolitano V, Dabrowska A, Schorpp K, Mourão A, Barreto-Duran E, Benedyk M, Botwina P, Brandner S, Bostock M, Chykunova Y, Czarna A, Dubin G, Fröhlich T, Hölscher M, Jedrysik M, Matsuda A, Owczarek K, Pachota M, Plettenburg O, Potempa J, Rothenaigner I, Schlauderer F, Slysz K, Szczepanski A, Greve-Isdahl Mohn K, Blomberg B, Sattler M, Hadian K, Popowicz GM, Pyrc K. Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol 2022:S2451-9456(21)00513-4. [PMID: 35021060 DOI: 10.1016/j.chembiol.2021.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
671 Yam WC, Chan KH, Chow KH, Poon LL, Lam HY, Yuen KY, Seto WH, Peiris JS. Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol 2005;33:19-24. [PMID: 15797361 DOI: 10.1016/j.jcv.2004.09.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
672 Demmler GJ, Ligon BL. Severe acute respiratory syndrome (SARS): a review of the history, epidemiology, prevention, and concerns for the future. Semin Pediatr Infect Dis 2003;14:240-4. [PMID: 12913837 DOI: 10.1016/s1045-1870(03)00056-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
673 Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2012;2:264-75. [PMID: 22572391 DOI: 10.1016/j.coviro.2012.04.004] [Cited by in Crossref: 257] [Cited by in F6Publishing: 238] [Article Influence: 25.7] [Reference Citation Analysis]
674 Xiao M, Tian F, Liu X, Zhou Q, Pan J, Luo Z, Yang M, Yi C. Virus Detection: From State-of-the-Art Laboratories to Smartphone-Based Point-of-Care Testing. Adv Sci (Weinh) 2022;9:e2105904. [PMID: 35393791 DOI: 10.1002/advs.202105904] [Reference Citation Analysis]
675 Zhou B, Cheng L, Song S, Guo H, Shen S, Wang H, Ge X, Liu L, Ju B, Zhang Z. Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. Virol J 2022;19. [DOI: 10.1186/s12985-022-01827-w] [Reference Citation Analysis]
676 Hu H, Huang X, Tao L, Huang Y, Cui BA, Wang H. Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model. Vaccine 2009;27:1758-63. [PMID: 19186202 DOI: 10.1016/j.vaccine.2009.01.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
677 Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, Yang CF, Chen PJ, Yeh SH, Kao CL, Huang LM, Hsueh PR, Wang JT, Sheng WH, Fang CT, Hung CC, Hsieh SM, Su CP, Chiang WC, Yang JY, Lin JH, Hsieh SC, Hu HP, Chiang YP, Wang JT, Yang PC, Chang SC; SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004;10:1213-9. [PMID: 15324540 DOI: 10.3201/eid1007.031113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 116] [Article Influence: 7.3] [Reference Citation Analysis]
678 Hsieh PK, Chang SC, Huang CC, Lee TT, Hsiao CW, Kou YH, Chen IY, Chang CK, Huang TH, Chang MF. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol 2005;79:13848-55. [PMID: 16254320 DOI: 10.1128/JVI.79.22.13848-13855.2005] [Cited by in Crossref: 117] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
679 Martinez MA. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrob Agents Chemother 2020;64:e00399-20. [PMID: 32152082 DOI: 10.1128/AAC.00399-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003;77:8801-11. [PMID: 12885899 DOI: 10.1128/jvi.77.16.8801-8811.2003] [Cited by in Crossref: 777] [Cited by in F6Publishing: 578] [Article Influence: 40.9] [Reference Citation Analysis]
681 Pennington H. Politics, media and microbiologists. Nat Rev Microbiol 2004;2:259-62. [PMID: